Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Proteins Involved in Atherosclerosis	21/200	3.626257360546543E-19	3.1475913889543994E-16	0	0	19.907724908495474	845.3002287329988	CSF3;CSF2;CXCL8;ADM;CXCL1;FOS;TNF;THBS1;CXCL5;CX3CL1;ICAM1;NFKBIA;CXCL10;IL1A;CXCL11;PLAU;IL1B;CCL5;CCL4;CCL2;HSPA1A
TLR2 Induced Synovial Fibroblast Activation in Rheumatoid Arthritis	11/35	3.7541403953816876E-16	1.6292969315956525E-13	0	0	72.16567460317461	2563.216668661883	NFKBIA;CXCL10;CXCL8;CCL20;CCL5;IL1B;FOS;TICAM1;CXCL2;TNF;ICAM1
Proteins Involved in HIV Type 1 Infection	13/88	3.1727393722104324E-14	9.179792583595518E-12	0	0	27.660645161290322	859.736996119533	STAT5A;CSF2;CCL22;CSF1;TNF;THBS1;ICAM1;NFKBIA;PLAU;IL1B;CCL5;CCL4;CCL2
Proteins Involved in Myocarditis	17/207	6.554287439656258E-14	1.4222803744054079E-11	0	0	14.668464912280701	445.27697547333844	SERPINA3;CSF3;CSF2;CSF1;ADM;TICAM1;TNF;CXCL2;THBS1;ICAM1;CXCL10;PLAU;IL1B;IRF1;CCL5;BDKRB2;CCL2
Proteins Involved in Glomerulonephritis	14/121	1.0330635389628523E-13	1.7933983036395115E-11	0	0	21.015424359851075	628.3838327213116	CSF2;CXCL8;CSF1;LIF;ADM;TNF;CXCL2;CX3CL1;ICAM1;CXCL10;IL1B;CCL5;CCL2;CFB
IL17 Signaling in Psoriasis	10/41	1.5250994983249082E-13	2.2063106075767003E-11	0	0	50.37338074676149	1486.5963711006536	NFKBIA;CSF3;CSF2;CXCL8;CCL20;CCL2;CXCL1;FOS;CXCL2;CXCL5
ROS in Triggering Vascular Inflammation	9/32	6.24410963054449E-13	7.382055456707348E-11	0	0	60.65217391304348	1704.445429126521	NFKBIA;CSF2;CXCL8;PLAU;CCL5;CCL2;CXCL2;TNF;ICAM1
IL1B Expression Targets -> Nociception	10/47	6.803737748117372E-13	7.382055456707348E-11	0	0	42.19195573526282	1182.0554889306572	NFKBIA;CSF3;CXCL8;PLAU;IL1B;CCL2;FOS;TNF;CX3CL1;ICAM1
Cytokines Trigger Otitis Media	11/71	1.870520147868494E-12	1.7776347534356263E-10	0	0	28.81388888888889	778.1134383403564	NFKBIA;IL1A;CSF3;CXCL8;CCL20;IL1B;CCL2;CXCL1;TNF;CXCL5;ICAM1
Neutrophil Recruitment in Sinovium in Gout	9/36	2.0479663058014127E-12	1.7776347534356263E-10	0	0	51.65625	1390.2852935141016	NFKBIA;CSF3;CXCL8;IL1B;CCL2;CXCL1;CXCL2;TNF;ICAM1
Proteins Involved in Rheumatoid Arthritis	12/96	2.5037217325878788E-12	1.9756640580784352E-10	0	0	22.60457142857143	603.8414049167092	IL1A;CXCL10;CSF2;CXCL8;TNFSF14;IL1B;CCL5;CCL2;ADM;TNF;CX3CL1;ICAM1
Endothelial Cell Dysfunction in Glomerulonephritis	10/55	3.669295915340977E-12	2.6541240454299727E-10	0	0	34.67716535433071	913.0851802949321	NFKBIA;IL1A;CXCL8;IL1B;BDKRB2;CCL2;FOS;CXCL2;TNF;ICAM1
Proteins Involved in Psoriasis	10/59	7.701581141601314E-12	5.142286485315339E-10	0	0	31.83994857785634	814.7714037364142	CXCL10;CSF3;CXCL11;CSF2;CXCL8;CCL20;IL1B;CCL5;TNF;ICAM1
Nociception Expression Targets Signaling	13/143	1.8401402234793198E-11	1.1408869385571782E-9	0	0	15.913709677419355	393.3645324616638	STAT5A;CXCL8;FOS;TNF;ICAM1;NFKBIA;CXCL10;CXCL11;IL1B;CCL5;CCL4;BDKRB2;CCL2
Proteins Involved in Systemic Scleroderma	9/49	4.14618022749379E-11	2.399256291643073E-9	0	0	34.8451171875	833.0160318777779	IL1A;CXCL10;CXCL8;CCL22;IL1B;CCL2;TNF;CX3CL1;ICAM1
Macrophage M1 Lineage	9/51	6.069347990093386E-11	3.11283923839453E-9	0	0	33.18247767857143	780.6239207968732	STAT5A;NFKBIA;CXCL10;CSF2;IL23A;IL1B;CCL5;TICAM1;TNF
Alveolar Macrophages Dysfunction in COPD	10/72	6.096574545242742E-11	3.11283923839453E-9	0	0	25.14732029464059	591.4828017601526	NFKBIA;IL1A;CXCL8;IL1B;CCL2;CXCL1;FOS;TICAM1;TNF;HSPA1A
Tumor Infiltrating Macrophages in Cancer Progression and Immune Escape	8/36	1.0151925640045927E-10	4.895484141977702E-9	0	0	43.93133997785161	1010.8940749996824	CXCL8;CCL22;CSF1;PLAU;CCL5;IL1B;CCL2;CX3CL1
Endothelial Cell Dysfunction in Pyelonephritis	8/37	1.287829138353899E-10	5.8833457478483385E-9	0	0	42.414327719861	965.8969454577611	NFKBIA;CXCL8;IL1B;CXCL1;CXCL2;TNF;CXCL5;ICAM1
Vascular Endothelial Cell Activation by Blood Coagulation Factors	9/57	1.7336851377986971E-10	7.524193498046346E-9	0	0	29.02587890625	652.3740918235283	NFKBIA;CXCL8;IL1B;BDKRB2;CCL2;FOS;CXCL2;TNF;ICAM1
Hodgkin and Reed-Sternberg Cells in Hodgkin Lymphoma	6/14	2.6555948816688413E-10	1.0976458844231211E-8	0	0	113.67366412213741	2506.41133605529	CCL22;CSF2;CXCL8;CCL20;CCL5;TNF
CCR1 Expression Targets	7/27	4.802145167795968E-10	1.894664548021318E-8	0	0	53.42346153846154	1146.295899243314	CXCL10;CXCL11;CCL5;CCL4;CCL2;TNF;ICAM1
Subepithelial Fibroblasts in Middle Ear Cholesteatoma	8/46	8.265404911400545E-10	3.11929194047638E-8	0	0	32.35414116687066	676.6471383744002	NFKBIA;IL1A;CSF2;CCL20;IL1B;FOS;TNF;ICAM1
Proteins Involved in Chronic Obstructive Pulmonary Disease	12/170	2.1341423476914458E-9	7.453346768726855E-8	0	0	11.9726582278481	239.03652780366872	CXCL10;SERPINA3;CSF3;CSF2;MAFB;CXCL8;IL1B;PTAFR;CCL4;CCL2;CXCL1;TNF
CXC Chemokine Receptor Signaling	9/75	2.181497699971011E-9	7.453346768726855E-8	0	0	21.090553977272727	420.61427871723373	STAT5A;NFKBIA;CXCL10;CXCL11;CXCL8;CXCL1;CXCL3;CXCL2;CXCL5
Leukocyte Migration toward the Endothelial Cell in Ulcerative Colitis	7/33	2.2325693086048183E-9	7.453346768726855E-8	0	0	41.08254437869822	818.3689164244936	STAT5A;CXCL10;CXCL8;IL1B;CXCL1;CXCL3;ICAM1
Proteins Involved in Diabetic Nephropathy	12/175	2.9699415530161837E-9	9.547812103770545E-8	0	0	11.602453987730062	227.81097670666486	CXCL10;IL1A;CXCL8;CCL20;BDKRB2;CCL2;SOD2;ETS1;TNF;DKK1;THBS1;ICAM1
Proteins Involved in Multiple Sclerosis	8/54	3.1478446608298444E-9	9.758318448572518E-8	0	0	26.71654870239299	523.017794138371	CXCL10;CSF2;IL1B;CCL5;LIF;CCL2;TNF;ICAM1
Hodgkin Lymphoma	10/110	4.279375693029346E-9	1.2808614143274043E-7	0	0	15.561417322834645	299.86008847973505	STAT5A;NFKBIA;CSF2;CXCL8;CCL22;CCL20;CCL5;TNFAIP3;TNF;ICAM1
Toll-like Receptors in Sterile Inflammation	8/60	7.478778314974657E-9	2.1638598591326673E-7	0	0	23.626714370900416	442.0840925303389	NFKBIA;IL1A;CXCL8;IL1B;CCL5;TICAM1;TNF;HSPA1A
Cochlear Inflammation (Noise-Induced)	5/12	1.0678420889835868E-8	2.989957849154043E-7	0	0	107.44588744588745	1972.1736555012176	IL1B;CCL4;CCL2;TNF;ICAM1
Lipids Enhance Apoptotic Cell Engulfment and Reduce Inflammation	6/25	1.4722443381527955E-8	3.993462767239458E-7	0	0	47.83607874648453	862.6707135429044	CSF2;CXCL8;IL1B;CCL2;THBS1;TNF
Toll-like Receptor Independent Sterile Inflammation	8/66	1.621988949063224E-8	4.266322447839026E-7	0	0	21.176156107992515	379.83729660139966	NFKBIA;IL1A;IL1B;CCL2;CXCL1;FOS;CXCL2;TNF
Chemokines Signaling in Atherosclerosis	5/13	1.7257190863722965E-8	4.4056593146210395E-7	0	0	94.01041666666667	1680.4396686558991	CXCL10;CCL5;CCL2;CXCL1;CX3CL1
Proteins Involved in Pulmonary Hypertension	11/165	1.8633309473852126E-8	4.621060749515327E-7	0	0	11.172902494331066	198.85883834807368	TNFSF14;PLAU;IL1B;ID1;PTAFR;CCL2;ADM;SOD2;TNF;THBS1;CX3CL1
Proteins Involved in Myocardial Ischemia	13/252	1.9811642786809604E-8	4.776807205264093E-7	0	0	8.608179241463086	152.68324122526553	CSF3;CXCL8;CSF1;LIF;ADM;FOS;SOD2;TNF;CXCL5;ICAM1;BDKRB2;CCL2;HSPA1A
Plasmin Effects in Inflammation	8/68	2.0636806669146565E-8	4.841283294275465E-7	0	0	20.468217054263565	362.2094502563104	NFKBIA;IL1A;PLAU;CCL20;IL1B;CCL2;FOS;TNF
Proteins Involved in Endometriosis	13/256	2.3874597991484117E-8	5.453460804370583E-7	0	0	8.464755077658303	148.56026742947026	OXTR;DUSP2;CXCL8;CSF1;FOS;TNF;THBS1;ICAM1;IL1A;IL1B;CYP1A1;CCL2;BIRC3
Toll-like Receptors in beta-Cell	7/46	2.5976331166343182E-8	5.781398833945098E-7	0	0	27.370414201183433	478.0538455296257	NFKBIA;CXCL10;CCL5;IL1B;CCL2;TICAM1;TNF
Keep out Signal: LTF Inhibits Neutrophil Recruitment and Inflammation	5/14	2.6697168540723868E-8	5.793285573337079E-7	0	0	83.56060606060606	1457.1890364949425	CSF2;CXCL8;IL1B;CCL2;TNF
Majeed Syndrome	6/29	3.861107388653502E-8	8.174246861832292E-7	0	0	39.508795220710255	674.4043371919433	NFKBIA;IL1B;CCL2;FOS;TICAM1;TNF
NF-kB Signaling Activation in Huntington Disease	5/15	3.98259353488064E-8	8.230693305419989E-7	0	0	75.20075757575758	1281.3267197624787	NFKBIA;CXCL8;IL1B;CCL2;TNF
Mast-Cell Activation without Degranulation	7/49	4.0982988416479906E-8	8.272845103605712E-7	0	0	25.411538461538463	432.2530333204252	STAT5A;NFKBIA;IL1A;CXCL8;CCL2;FOS;TNF
NFKB Canonical Signaling Activation in Cancer	8/75	4.524531848693588E-8	8.678812281824248E-7	0	0	18.323267384010183	309.8678279554545	NFKBIA;IL1A;TNFSF14;NFKBIZ;TNFAIP3;LTB;TICAM1;TNF
Cortisol in Resolving Inflammation	7/50	4.738417055356742E-8	8.678812281824248E-7	0	0	24.81932021466905	418.57727992893035	NFKBIA;CSF2;CXCL8;FOS;TICAM1;TNF;HSPA1A
Plasmin Role in Glomerulonephritis	7/50	4.738417055356742E-8	8.678812281824248E-7	0	0	24.81932021466905	418.57727992893035	NFKBIA;IL1A;CCL20;IL1B;CCL2;FOS;TNF
Proteins Involved in Acne Vulgaris	7/50	4.738417055356742E-8	8.678812281824248E-7	0	0	24.81932021466905	418.57727992893035	IL1A;CSF3;CD83;CXCL8;CYP1A1;ADM;TNF
TNFR/NF-kB Classical Pathway in Multiple Myeloma Plasma Cells	6/30	4.799343197322165E-8	8.678812281824248E-7	0	0	37.86068702290076	638.0359330478833	NFKBIA;IL1A;CXCL8;LTB;TNF;ICAM1
Proplatelet Maturation	8/79	6.837795732014645E-8	1.2112666725283086E-6	0	0	17.28747679877716	285.2125146635189	NFKBIA;CSF2;CXCL8;CCL5;CCL2;ETS1;TNF;ICAM1
Hepatic Stellate Cells in non-Alcoholic Fatty Liver Disease	7/55	9.356620929789689E-8	1.592460189619108E-6	0	0	22.228365384615383	359.75712528070767	NFKBIA;IL1A;CXCL8;PLAU;CCL2;FOS;TNF
NFKB Signaling Activation by Blocking of Tumor Suppressors	7/55	9.356620929789689E-8	1.592460189619108E-6	0	0	22.228365384615383	359.75712528070767	NFKBIA;IL1A;TNFSF14;NFKBIZ;TNFAIP3;LTB;TNF
HPV E6 and E7 Induced Disruption of TNFR/NF-kB Signaling in Keratinocytes	7/57	1.2052395193402972E-7	2.011822889975727E-6	0	0	21.337076923076925	339.92987711786185	NFKBIA;IL1A;CXCL8;IL1B;TNFAIP3;TICAM1;TNF
Proteins Involved in Osteoarthritis	8/86	1.3359467484329148E-7	2.187927882339189E-6	0	0	15.73047107930829	248.98906045975752	IL1A;CXCL8;SDC4;PLAU;IL1B;CCL5;TNF;THBS1
Proteins Involved in Psoriatic Arthritis	7/59	1.5375802994999215E-7	2.4715179628998735E-6	0	0	20.514349112426036	321.8267641739824	NFKBIA;CSF1;IL23A;IL1B;CYP1A1;TNFAIP3;TNF
Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling	8/90	1.9073992872119474E-7	3.010222875090855E-6	0	0	14.96010588012857	231.46806851365153	NFKBIA;IL1A;CSF2;CXCL8;PLAU;CCL4;CCL2;TNF
Neutrophil Recruitment and Priming	7/66	3.373024746739153E-7	5.136465754683482E-6	0	0	18.07405475880052	269.34472882483516	STAT5A;NFKBIA;CSF3;CSF2;CXCL8;FOS;TNF
Proteins Involved in Inflammatory Bowel Diseases	7/66	3.373024746739153E-7	5.136465754683482E-6	0	0	18.07405475880052	269.34472882483516	CXCL10;CXCL8;TNFSF14;CCL20;IL1B;CCL2;TNF
CD16/CD14 Proinflammatory Monocyte Activation	7/67	3.7451827377003657E-7	5.509862061565962E-6	0	0	17.771923076923077	262.9822574875883	NFKBIA;CSF2;CSF1;FOS;TICAM1;TNF;CX3CL1
Alveolar Epithelial Cell Dysfunction in COPD	7/67	3.7451827377003657E-7	5.509862061565962E-6	0	0	17.771923076923077	262.9822574875883	NFKBIA;CSF2;CXCL8;IL1B;FOS;SOD2;TNF
HMGB1 and IL1B in Neuroinflammation	5/23	4.2703349488278526E-7	5.999494991621457E-6	0	0	41.76136363636363	612.4890049754347	NFKBIA;IL1B;CCL2;TICAM1;TNF
Toll-like Receptors (TLR) in Antiviral Innate Immune Response	5/23	4.2703349488278526E-7	5.999494991621457E-6	0	0	41.76136363636363	612.4890049754347	NFKBIA;CXCL8;IL1B;TICAM1;TNF
Neuroinflammation in Amyotrophic Lateral Sclerosis	4/10	4.285353565443898E-7	5.999494991621457E-6	0	0	99.53383458646617	1459.4539256078906	IL1B;CCL2;TNF;CX3CL1
T-Cell Cytotoxic Activation	6/43	4.5806630217597025E-7	6.3111357188689234E-6	0	0	24.54219104600784	358.22400265436613	NFKBIA;CCL20;IL1B;FOS;TNF;HSPA1A
Alveolar Macrophage Negative Regulation Declined in COPD	6/44	5.274233503074082E-7	6.8476411935407205E-6	0	0	23.89513860988349	345.41049605289356	NFKBIA;IL1A;CXCL8;IL1B;FOS;TNF
Antiphospholipid Antibodies and Endothelial Cell Interaction	5/24	5.364511534110241E-7	6.8476411935407205E-6	0	0	39.56140350877193	571.1990295551719	NFKBIA;IL1A;CXCL8;FOS;ICAM1
Antiphospholipid Antibodies in Endothelial Cell	5/24	5.364511534110241E-7	6.8476411935407205E-6	0	0	39.56140350877193	571.1990295551719	NFKBIA;IL1A;CXCL8;FOS;ICAM1
Microangiopathy in Diabetic Neuropathy	5/24	5.364511534110241E-7	6.8476411935407205E-6	0	0	39.56140350877193	571.1990295551719	NFKBIA;IL1A;CCL2;FOS;ICAM1
Proteins Involved in Graves Disease	5/24	5.364511534110241E-7	6.8476411935407205E-6	0	0	39.56140350877193	571.1990295551719	CXCL10;IL1A;IL1B;TNF;ICAM1
Dendritic Cells Function in Atherosclerosis	6/45	6.05158803567082E-7	7.612722340525032E-6	0	0	23.28126834997064	333.3359602761352	NFKBIA;CXCL8;CCL22;FOS;TICAM1;TNF
Eosinophil Survival by Cytokine Signaling	7/72	6.166176190993368E-7	7.646058476831776E-6	0	0	16.400710059171598	234.51402780372302	STAT5A;NFKBIA;CSF2;CXCL8;CCL2;TNF;ICAM1
Endothelial Cell Dysfunction in Early Diabetic Nephropathy	5/25	6.668850805262436E-7	8.03967013745527E-6	0	0	37.58143939393939	534.4324246728171	NFKBIA;IL1A;CCL2;FOS;ICAM1
Proteins Involved in Chronic Bronchitis	5/25	6.668850805262436E-7	8.03967013745527E-6	0	0	37.58143939393939	534.4324246728171	CXCL8;CYP1B1;CXCL2;TNF;ICAM1
Proteins Involved in Glioma	12/290	7.634144887684576E-7	9.077312003438647E-6	0	0	6.7631654676259	95.26232857322141	CXCL10;IL1A;CXCL8;PLAU;IL1B;LIF;CCL2;ADM;ETS1;TNF;DKK1;HSPA1A
Keratinocyte Activation in Psoriatic Arthritis	6/47	7.888708250102835E-7	9.253241569039541E-6	0	0	22.143362502327314	311.1732164543684	NFKBIA;CXCL8;CCL20;CCL2;FOS;TNF
IL23A and IL17A Provoke Cancer-Associated Inflammation	5/26	8.211378513197537E-7	9.503302065940617E-6	0	0	35.79004329004329	501.51065994916723	NFKBIA;IL23A;IL1B;TNF;ICAM1
Nicotine anti-Inflammatory Effect in Ulcerative Colitis	5/28	1.2134169282376958E-6	1.3858498601451578E-5	0	0	32.674571805006586	445.0953131849194	NFKBIA;IL23A;IL1B;TICAM1;TNF
Inflammatory Reaction in Acne Vulgaris	6/51	1.2937546513288251E-6	1.4397167145556669E-5	0	0	20.170992366412214	273.47754769767596	NFKBIA;CXCL8;IL1B;FOS;TNF;CFB
Synovial Fibroblast Activation by Citokines in Rheumatoid Arthritis	6/51	1.2937546513288251E-6	1.4397167145556669E-5	0	0	20.170992366412214	273.47754769767596	NFKBIA;CXCL8;IL1B;LIF;FOS;TNF
Toll-like Receptors (TLR) in Periodontitis	5/29	1.4581711444364672E-6	1.6021424726213334E-5	0	0	31.31155303030303	420.774905665651	NFKBIA;CXCL8;IL1B;TICAM1;TNF
IL36 Receptor Antagonist (IL1F5) Deficiency (DITRA)	5/30	1.7402100678900754E-6	1.8881279236607318E-5	0	0	30.05757575757576	398.60868288161646	NFKBIA;IL1A;CXCL8;IL1B;TNF
Genes with Mutations Associated with Psoriatic Arthritis	4/14	1.999652707338003E-6	2.0912030722522734E-5	0	0	59.70827067669173	783.523993478395	NFKBIA;IL23A;TNFAIP3;TNF
Microglia Activation in Alzheimer's Disease	4/14	1.999652707338003E-6	2.0912030722522734E-5	0	0	59.70827067669173	783.523993478395	NFKBIA;IL1A;IL1B;TNF
Proteins with Altered Expression in Psoriatic Arthritis	4/14	1.999652707338003E-6	2.0912030722522734E-5	0	0	59.70827067669173	783.523993478395	IL1A;CXCL8;IL23A;TNF
Proteins Involved in Otitis Media	5/31	2.0634891774793442E-6	2.1322721500619893E-5	0	0	28.900058275058274	378.33390640479115	CXCL8;CCL5;IL1B;TICAM1;TNF
Eosinophil Activation	7/87	2.2460317566552627E-6	2.2890338544674475E-5	0	0	13.315480769230769	173.18574421600607	NFKBIA;IL1A;CSF2;CXCL8;EGOT;PTAFR;TNF
TLR4 Signaling in Leukocytes	6/56	2.2679367682511574E-6	2.2890338544674475E-5	0	0	18.149312977099235	235.88008796256815	NFKBIA;CXCL8;IL1B;CCL5;TICAM1;TNF
CC Chemokine Receptor Signaling	7/88	2.426308814448699E-6	2.3990421651018377E-5	0	0	13.15042735042735	170.0237091968831	STAT5A;NFKBIA;CCL22;CCL20;CCL5;CCL4;CCL2
Coagulation Factors and PAR1/2 Receptors (F2R/F2RL1) in Endometriosis	5/32	2.4322086466470243E-6	2.3990421651018377E-5	0	0	27.828282828282827	359.72816433023917	NFKBIA;CXCL8;CCL2;FOS;TNF
beta-Cell Destruction through Cytokines in Diabetes Mellitus	6/57	2.520576226868548E-6	2.4582698482268534E-5	0	0	17.792546026044004	229.36412042614543	NFKBIA;IL1B;TNFAIP3;CCL2;FOS;TNF
Hypothalamic-Pituitary-Adrenal Axis in Acute Phase Response	5/33	2.850817425060075E-6	2.7192412362111484E-5	0	0	26.83306277056277	342.6019906517243	IL1A;IL1B;FOS;TNF;ICAM1
Autocrine Cytokine/Chemokine Loops in Systemic Scleroderma	5/33	2.850817425060075E-6	2.7192412362111484E-5	0	0	26.83306277056277	342.6019906517243	NFKBIA;IL1A;IL1B;CCL2;FOS
Positive Acute Phase Proteins Synthesis	6/59	3.094778789214897E-6	2.8744262403717246E-5	0	0	17.119400835373757	217.17319459191765	STAT5A;NFKBIA;SERPINA3;IL1A;IL1B;TNF
Antigen-Presenting Cell Role in Asthma	6/59	3.094778789214897E-6	2.8744262403717246E-5	0	0	17.119400835373757	217.17319459191765	NFKBIA;CSF2;CCL22;IL1B;TICAM1;TNF
Proteins with Altered Expression in Pyelonephritis	3/5	3.112857910079978E-6	2.8744262403717246E-5	0	0	222.32462686567163	2819.0694458683197	CXCL8;IL1B;TNF
Diabetes Induced Periodontitis	5/34	3.32401706639395E-6	2.9744812511648957E-5	0	0	25.906478578892372	326.7930395337648	NFKBIA;CXCL8;IL1B;FOS;TNF
Monocytes Function in Gout	5/34	3.32401706639395E-6	2.9744812511648957E-5	0	0	25.906478578892372	326.7930395337648	NFKBIA;CXCL8;IL1B;TICAM1;TNF
TSLP Signaling in Bronchial Epithelial Cell in Asthma	5/34	3.32401706639395E-6	2.9744812511648957E-5	0	0	25.906478578892372	326.7930395337648	STAT5A;NFKBIA;IL1B;FOS;TICAM1
Fatty Acids in Hypertension and Atherosclerosis Development	4/16	3.597242481971935E-6	3.186129055460857E-5	0	0	49.75187969924812	623.6568760911038	NFKBIA;IL1B;CCL2;TNF
Proteins Involved in Diabetes Mellitus Type 1	7/97	4.665098562897551E-6	4.0212676823859674E-5	0	0	11.83	145.21800087738518	CXCL10;CSF2;IL1B;CCL4;CCL2;TNF;ICAM1
Genes with Mutations Associated with Systemic Scleroderma	4/17	4.67912483779934E-6	4.0212676823859674E-5	0	0	45.9224985540775	563.5792467320659	IL1A;CXCL8;CCL2;TNF
Microglia Activation in Parkinson's Disease	4/17	4.67912483779934E-6	4.0212676823859674E-5	0	0	45.9224985540775	563.5792467320659	NFKBIA;IL1A;IL1B;TNF
anti-Inflammatory Function of Macrophage M2 Lineage	6/64	5.007273663612402E-6	4.261091705897612E-5	0	0	15.63964201105554	190.87587157067145	NFKBIA;CCL22;CSF1;IL1B;FOS;TNF
Plasmacytoid Dendritic Cell in Diabetes Mellitus Type 1	5/37	5.122039215362013E-6	4.27493272974445E-5	0	0	23.474195075757574	285.9616564768856	NFKBIA;IL1B;IRF1;TICAM1;TNF
Proteins Involved in Cholesteatoma	5/37	5.122039215362013E-6	4.27493272974445E-5	0	0	23.474195075757574	285.9616564768856	IL1A;CXCL8;FOS;TNF;ICAM1
Proteins Involved in Polycystic Ovary Syndrome	7/99	5.345160072153953E-6	4.418665659647269E-5	0	0	11.57165551839465	140.4720184586848	DNAJB1;CYP1A1;CCL2;ADM;FOS;TNF;DKK1
Proteins Involved in Helicobacter Infections	6/65	5.485653744457656E-6	4.492025896404949E-5	0	0	15.373787035839047	186.22843652229642	NFKBIA;CXCL8;CCL20;IL1B;SOD2;TNF
Mast-Cell Activation without Degranulation through IL1R1 and TLR Signaling	4/18	5.984098986695791E-6	4.8094425189369875E-5	0	0	42.64017185821697	512.8079664652752	NFKBIA;IL1A;CXCL8;TNF
Toll-like Receptors in Pyelonephritis	4/18	5.984098986695791E-6	4.8094425189369875E-5	0	0	42.64017185821697	512.8079664652752	NFKBIA;CXCL8;IL1B;TNF
Bradykinin Effects in Inflammation	5/39	6.69154553381798E-6	5.328680296655052E-5	0	0	22.091131907308377	263.2084513673578	NFKBIA;IL1A;PLAU;IL1B;BDKRB2
IL1 Receptor Antagonist (IL1RN) Deficiency (DIRA)	5/40	7.605589517365801E-6	6.001501546430468E-5	0	0	21.458874458874458	252.92775162261003	NFKBIA;IL1A;IL1B;TICAM1;TNF
Toll-like Receptors Act through MYD88-TIRAP Signaling	5/41	8.614478805121845E-6	6.736367209770957E-5	0	0	20.861742424242426	243.29102095581163	NFKBIA;CXCL8;IL1B;TNF;HSPA1A
Clozapine Induced Granulocytopenia	5/42	9.725044883463881E-6	7.536909784684508E-5	0	0	20.2968877968878	234.24244554752926	NFKBIA;CSF3;CSF2;IRF1;FOS
Dendritic Cell Dysfunction in Crohn's disease	5/43	1.0944395753703431E-5	8.333101328258402E-5	0	0	19.76176236044657	225.73234767677945	NFKBIA;IL23A;IL1B;TICAM1;TNF
Proteins Involved in Atopic Dermatitis	5/43	1.0944395753703431E-5	8.333101328258402E-5	0	0	19.76176236044657	225.73234767677945	CSF2;CCL22;CCL5;IL1B;TNF
TRPM7/8 in Pancreatic Adenocarcinoma	4/21	1.1518940861420315E-5	8.694296232793768E-5	0	0	35.11012826183105	399.255450106025	CXCL8;IL1B;FOS;TNF
TAM Receptor Signaling Activation in Cancer	6/74	1.1698077412442063E-5	8.753388960344578E-5	0	0	13.332959137853615	151.41023131574602	CSF2;CXCL8;IL1B;CXCL1;FOS;CXCL2
MC1R in anti-Inflammatory Signaling	5/44	1.2279917527594321E-5	9.03302407962023E-5	0	0	19.254079254079254	217.7163743622897	NFKBIA;CXCL8;IL1B;TICAM1;TNF
Adipokines Production by Adipocyte Impaired in Obesity	5/44	1.2279917527594321E-5	9.03302407962023E-5	0	0	19.254079254079254	217.7163743622897	NFKBIA;IL1B;CCL2;FOS;TNF
Low-Density Lipoproteins and Chemokines in Atherosclerosis	4/22	1.4004054579607567E-5	1.0129599479249474E-4	0	0	33.1578947368421	370.5780581154342	CCL5;CCL2;CX3CL1;ICAM1
TNF-alpha/TNFRSF1B Signaling	4/22	1.4004054579607567E-5	1.0129599479249474E-4	0	0	33.1578947368421	370.5780581154342	NFKBIA;FOS;TNF;BIRC3
Adipokines Production by Adipocyte	5/46	1.5330416901121387E-5	1.0818538105832002E-4	0	0	18.3130081300813	203.01199542625278	NFKBIA;IL1B;CCL2;FOS;TNF
Apoptotic Keratinocytes Clearance Recession in Systemic Lupus Erythematosus	5/46	1.5330416901121387E-5	1.0818538105832002E-4	0	0	18.3130081300813	203.01199542625278	NFKBIA;IL1A;IL1B;TICAM1;HSPA1A
Dendritic Cell Function in Ulcerative Colitis	5/46	1.5330416901121387E-5	1.0818538105832002E-4	0	0	18.3130081300813	203.01199542625278	NFKBIA;IL23A;IL1B;TICAM1;TNF
Glucocorticoid Resistance	3/8	1.71710540690056E-5	1.201973784830392E-4	0	0	88.91641791044776	975.6163224867458	CSF2;CXCL8;TNF
Multiple Myeloma	7/121	2.0009767871773718E-5	1.389478281015967E-4	0	0	9.328137651821862	100.9238265086989	NFKBIA;MAFB;FOS;LTB;TNF;DKK1;ICAM1
Eosinophil Survival in Asthma	5/50	2.3181611457894815E-5	1.5843810035789528E-4	0	0	16.681818181818183	178.03088597976304	STAT5A;NFKBIA;CSF2;CXCL8;CCL2
Synovial Fibroblast Activation in Psoriatic Arthritis	5/50	2.3181611457894815E-5	1.5843810035789528E-4	0	0	16.681818181818183	178.03088597976304	NFKBIA;CXCL8;IL1B;FOS;TNF
Familial Mediterranean Fever	4/25	2.3834468553262855E-5	1.6162748987681375E-4	0	0	28.41675617615467	302.4786876364136	NFKBIA;IL1B;TICAM1;TNF
Airway Epithelial Cell Dysfunction	5/51	2.556074640415341E-5	1.685197742048563E-4	0	0	16.3183465085639	172.55758373501786	NFKBIA;CXCL8;IL1B;TICAM1;TNF
Scavenger Receptor OLR1 in Inflammation Related Endothelial Dysfunction	5/51	2.556074640415341E-5	1.685197742048563E-4	0	0	16.3183465085639	172.55758373501786	NFKBIA;CXCL8;CCL2;CXCL2;ICAM1
Proteins Involved in Pyelonephritis	3/9	2.5627431100277682E-5	1.685197742048563E-4	0	0	74.09328358208955	783.302876488232	CSF3;CXCL8;TNF
Asbestosis- and Silicosis-Associated Inflammation Provokes Cancer Development	3/9	2.5627431100277682E-5	1.685197742048563E-4	0	0	74.09328358208955	783.302876488232	IL1B;FOS;TNF
Mast-Cell Activation via IgE Signaling	6/86	2.7760092244822514E-5	1.769039408294319E-4	0	0	11.326145038167938	118.83290683926535	STAT5A;NFKBIA;CXCL8;CCL5;CCL2;TNF
Cryopyrin (NLPR3) Associated Periodic Syndromes	4/26	2.8018749264554997E-5	1.769039408294319E-4	0	0	27.12371838687628	284.3280845900592	NFKBIA;IL1B;TICAM1;TNF
Microglia and Motor Neuron Interaction Dysregulation	4/26	2.8018749264554997E-5	1.769039408294319E-4	0	0	27.12371838687628	284.3280845900592	IL1B;FOS;TNF;CX3CL1
PAPA Syndrome	4/26	2.8018749264554997E-5	1.769039408294319E-4	0	0	27.12371838687628	284.3280845900592	NFKBIA;IL1B;TICAM1;TNF
Prolactin Production	5/52	2.812528091527834E-5	1.769039408294319E-4	0	0	15.970341715022567	167.35068287660204	OXTR;LIF;FOS;ETS1;TNF
NF-kB Canonical Signaling	5/52	2.812528091527834E-5	1.769039408294319E-4	0	0	15.970341715022567	167.35068287660204	NFKBIA;IL1A;LTB;TICAM1;TNF
Muscular Dystrophies	5/53	3.0885144724181695E-5	1.9286550806179648E-4	0	0	15.636837121212121	162.39223195904628	NFKBIA;IL1B;FOS;SOD2;TNF
Dendritic Cell Activation in Systemic Lupus Erythematosis	5/55	3.703199877714211E-5	2.295983924182811E-4	0	0	15.009848484848485	153.15641407130462	NFKBIA;IL1A;IL1B;TICAM1;TNF
Familial Cold Autoinflammatory Syndrome 2	4/28	3.796801280745469E-5	2.3208616279486385E-4	0	0	24.860902255639097	253.0533195602743	NFKBIA;IL1B;TICAM1;TNF
Il17 Signaling Related Neutrophilia in Asthma	4/28	3.796801280745469E-5	2.3208616279486385E-4	0	0	24.860902255639097	253.0533195602743	NFKBIA;CXCL8;CCL4;CXCL1
Macrophage Function in Diabetes Mellitus Type 1	4/29	4.38096379738759E-5	2.603198103393002E-4	0	0	23.865263157894738	239.503588578474	NFKBIA;IL1B;TNF;ICAM1
Mevalonate Kinase Deficiency	4/29	4.38096379738759E-5	2.603198103393002E-4	0	0	23.865263157894738	239.503588578474	NFKBIA;IL1B;TICAM1;TNF
TNFR -> NF-kB Signaling	4/29	4.38096379738759E-5	2.603198103393002E-4	0	0	23.865263157894738	239.503588578474	NFKBIA;TNFSF14;LTB;TNF
CFTR Facilitates Oxidative Stress in Airway Epithelium in CF	5/57	4.4086419492946E-5	2.603198103393002E-4	0	0	14.431089743589743	144.73457649413675	NFKBIA;CXCL8;IL1B;TNF;ICAM1
Osteoclast Activation in Rheumatoid Arthritis	5/57	4.4086419492946E-5	2.603198103393002E-4	0	0	14.431089743589743	144.73457649413675	NFKBIA;CSF1;IL1B;FOS;BIRC3
B-Cell Chronic Lymphocytic Leukemia	6/94	4.597126292093385E-5	2.696152446984499E-4	0	0	10.292331714087439	102.79460202065385	NFKBIA;CXCL10;CXCL11;CCL22;CCL4;FOS
Osteoclast Activation in Gout	5/58	4.7981801320985254E-5	2.795181446081557E-4	0	0	14.15809033733562	140.79780181377998	NFKBIA;CSF1;IL1B;FOS;BIRC3
Mast-Cell Activation without Degranulation through CXCR4 Signaling	3/11	4.983617204825292E-5	2.8647547905883135E-4	0	0	55.56436567164179	550.4633626362048	STAT5A;CXCL8;FOS
TNFRSF1A -> STAT Signaling	3/11	4.983617204825292E-5	2.8647547905883135E-4	0	0	55.56436567164179	550.4633626362048	STAT5A;LTB;TNF
RAGE/AGER and S100 Proteins in Cardiovascular Injury	4/30	5.028191239100909E-5	2.871361839170782E-4	0	0	22.94621168305379	227.11850871597983	NFKBIA;PLAU;CCL2;ICAM1
Follicular Lymphoma	6/97	5.486495542164551E-5	3.112600085358713E-4	0	0	9.951514134720242	97.63068031712935	STAT5A;NFKBIA;TNFSF14;PLK2;TNFAIP3;FOS
Proteins Involved in Periodontitis	5/61	6.128098297104937E-5	3.4540190401864196E-4	0	0	13.397591991341992	129.95719151024628	IL1A;CXCL8;IL1B;CCL5;TNF
Proteins Involved in Osteoporosis	6/100	6.508419032181117E-5	3.644714658021425E-4	0	0	9.632450868929674	92.8551781720776	CSF3;OXTR;IL1B;TNF;DKK1;ICAM1
TACR1 -> TNF/IL6/IL8 Production	3/12	6.611524436467678E-5	3.6787200069576565E-4	0	0	49.38805970149254	475.316179107482	NFKBIA;CXCL8;TNF
Proteins Involved in Arterial Hypertension	9/255	6.70617966630258E-5	3.7076203505418087E-4	0	0	5.606993140243903	53.88262109294085	CXCL8;IL1B;BDKRB2;CYP1B1;CCL2;ADM;SOD2;TNF;HSPA1A
Dendritic Cell Dysfunction in Psoriatic Arthritis	5/63	7.161384043691474E-5	3.9342287024836706E-4	0	0	12.934299895506792	123.44783221044729	NFKBIA;IL23A;IL1B;TNFAIP3;TNF
Proteins Involved in Age-Related Macular Degeneration	7/148	7.266877803620252E-5	3.967075429900867E-4	0	0	7.531587561374796	71.7730072501306	CXCL10;CXCL8;IL1B;CCL2;TNF;CFB;HSPA1A
OipA Signaling in Helicobacter Pylori Infection	4/34	8.330216171755053E-5	4.49107306651142E-4	0	0	19.882706766917295	186.75898159502256	NFKBIA;CXCL8;IRF1;FOS
Proteins Involved in Gout	4/34	8.330216171755053E-5	4.49107306651142E-4	0	0	19.882706766917295	186.75898159502256	CXCL8;PLAU;IL1B;TNF
Histamine Effects in Inflammation	3/13	8.55192106061155E-5	4.554029129209096E-4	0	0	44.44701492537313	416.32494473832645	IL1A;CSF2;CCL5
Mast-Cell Activation without Degranulation through TNFSF8 Signaling	3/13	8.55192106061155E-5	4.554029129209096E-4	0	0	44.44701492537313	416.32494473832645	NFKBIA;CXCL8;CCL2
Vascular Endothelial Cell Activation by Cytokines	5/66	8.957073766933294E-5	4.7381865082134363E-4	0	0	12.29632389468455	114.60766404901334	NFKBIA;IL1B;CCL2;TNF;ICAM1
Proteins Involved in Obesity	6/106	9.006921357778997E-5	4.7381865082134363E-4	0	0	9.051755725190839	84.31649035915024	IL1A;CXCL8;IL1B;CCL5;CCL2;TNF
Thymic Follicular Hyperplasia	4/36	1.0469071482191207E-4	5.474189184663836E-4	0	0	18.638157894736842	170.80940040584514	NFKBIA;IL1A;CCL22;TNF
Immune System Role in Otitis Media	4/37	1.1675973396444486E-4	5.996890478173854E-4	0	0	18.072453861927546	163.65315937104566	NFKBIA;IL23A;IL1B;TNF
TNF Receptor Associated Periodic Syndrome	4/37	1.1675973396444486E-4	5.996890478173854E-4	0	0	18.072453861927546	163.65315937104566	NFKBIA;IL1B;TICAM1;TNF
ERK5/MAPK7 Signaling	4/37	1.1675973396444486E-4	5.996890478173854E-4	0	0	18.072453861927546	163.65315937104566	RCAN1;CSF3;FOS;ETS1
TNF and IL1B Induce Metalloproteinase Synthesis in Osteoarthritis	4/38	1.2980617450249855E-4	6.627750556951102E-4	0	0	17.54002653693056	156.9739094645417	NFKBIA;IL1B;FOS;TNF
Adipose Tissue Inflammation Provokes Insulin Resistance	3/15	1.3469397645046206E-4	6.680821231942919E-4	0	0	37.03544776119403	330.07862052661784	CCL2;TNF;CXCL5
Estrogen Effects in Mitochondria in Alzheimer Disease	3/15	1.3469397645046206E-4	6.680821231942919E-4	0	0	37.03544776119403	330.07862052661784	CYP1B1;SOD2;HSPA1A
Proteins with Altered Expression in Osteoarthritis	3/15	1.3469397645046206E-4	6.680821231942919E-4	0	0	37.03544776119403	330.07862052661784	SDC4;IL1B;TNF
TLR3 Role in Retinal Pigment Epithelial Cell	3/15	1.3469397645046206E-4	6.680821231942919E-4	0	0	37.03544776119403	330.07862052661784	NFKBIA;SOD2;TICAM1
TLR7 and TLR9 in Plasmacytoid Dendritic Cell	3/15	1.3469397645046206E-4	6.680821231942919E-4	0	0	37.03544776119403	330.07862052661784	NFKBIA;CCL5;CCL2
FAS Mediated Apoptosis in Systemic Scleroderma	3/16	1.6494731177894314E-4	8.134901512734241E-4	0	0	34.18484500574053	297.7460502013013	CXCL8;IL1B;TNF
AXL Receptor Inhibits Macrophages and Dendritic Cells Function	4/41	1.752777710927742E-4	8.548594050599056E-4	0	0	16.115423694371064	139.38453279231203	NFKBIA;FOS;TICAM1;TNF
Mast-Cell Activation in Asthma	5/76	1.7530526970122487E-4	8.548594050599056E-4	0	0	10.559112249253094	91.32556866951651	STAT5A;NFKBIA;CXCL8;CCL5;CCL2
Osteoclast Activation in Postmenopause	4/42	1.9270449110476626E-4	9.344552976476934E-4	0	0	15.690542144835774	134.22243119422268	NFKBIA;CSF1;FOS;TNF
Vitiligo	5/78	1.981417053546344E-4	9.350507029185295E-4	0	0	10.268783727687838	87.55707300325491	STAT5A;CXCL8;IL1B;TNF;ICAM1
BDKRB1/2 -> Interleukins Production	3/17	1.9929076041466353E-4	9.350507029185295E-4	0	0	31.74147121535181	270.46100411619	NFKBIA;CXCL8;BDKRB2
Find me Signal: Apoptotic Cell Attracts Phagocyte	3/17	1.9929076041466353E-4	9.350507029185295E-4	0	0	31.74147121535181	270.46100411619	CXCL8;THBS1;CX3CL1
Leptin Role in Endometriosis	3/17	1.9929076041466353E-4	9.350507029185295E-4	0	0	31.74147121535181	270.46100411619	IL1B;FOS;TNF
Oxytocin Signaling in Brain Nerve Cell (Hypothesis)	3/17	1.9929076041466353E-4	9.350507029185295E-4	0	0	31.74147121535181	270.46100411619	OXTR;FOS;TNF
Proteins with Altered Expression in Tumor-Promoting Inflammation	3/17	1.9929076041466353E-4	9.350507029185295E-4	0	0	31.74147121535181	270.46100411619	IL23A;IL1B;TNF
Dendritic Cells Function in Psoriasis	4/43	2.1134667544843046E-4	9.81010236840843E-4	0	0	15.287449392712551	129.3625612716884	NFKBIA;IL23A;IL1B;TNF
Graves Ophthalmopathy	4/43	2.1134667544843046E-4	9.81010236840843E-4	0	0	15.287449392712551	129.3625612716884	IL1A;CCL5;IL1B;ICAM1
Proteins Involved in Glioblastoma	7/178	2.2878859756403518E-4	0.0010563218227956517	0	0	6.20080971659919	51.97960286139878	NFKBIA;IL1A;PLAU;IL1B;ADM;TNF;HSPA1A
IL6/IL12 Signaling Activates Immune System in Multiple Sclerosis	3/18	2.3795238151637095E-4	0.0010870666692432104	0	0	29.623880597014924	247.16506979433774	CXCL10;CXCL11;IL23A
Proteins Involved in Adhesion, Migration and Invasion of Endometriotic Cell	3/18	2.3795238151637095E-4	0.0010870666692432104	0	0	29.623880597014924	247.16506979433774	CXCL8;IL1B;TNF
Osteoarthritis	5/82	2.5055332663892943E-4	0.0011386402488093757	0	0	9.733372687918143	80.7075571070701	NFKBIA;SDC4;IL1B;FOS;TNF
Splenic Marginal Zone Lymphoma	4/45	2.5247451453155667E-4	0.0011413952011114124	0	0	14.54025307170365	120.45436808646765	NFKBIA;TNFAIP3;TNF;BIRC3
Proteins Involved in Alzheimer's Disease	6/130	2.7539806716351747E-4	0.0012385778357405864	0	0	7.2909381925634085	59.76595653629373	SERPINA3;CSF2;IL1B;CCL2;SOD2;TNF
Macrophage Related Iron Uptake and Release	3/19	2.8115508108417047E-4	0.0012515005660567178	0	0	27.77098880597015	227.07238234511914	CSF2;IL1B;TNF
Proteins with Altered Expression in Amyotrophic Lateral Sclerosis	3/19	2.8115508108417047E-4	0.0012515005660567178	0	0	27.77098880597015	227.07238234511914	IL1B;TNF;CX3CL1
Proteins Involved in non-Alcoholic Fatty Liver Disease	7/186	2.990304211384985E-4	0.0013044417135772892	0	0	5.9212720240653205	48.05091669220387	IL1A;CXCL8;IL1B;CCL2;CXCL1;TNF;ICAM1
IL6/IGF1/VEGFA Signaling in Multiple Myeloma	4/47	2.990597937809684E-4	0.0013044417135772892	0	0	13.862563385207205	112.49285850166679	CXCL8;FOS;TNF;ICAM1
Osteoclast Activation in Psoriatic Arthritis	4/47	2.990597937809684E-4	0.0013044417135772892	0	0	13.862563385207205	112.49285850166679	NFKBIA;IL1A;CSF1;BIRC3
Tubular Cell Dysfunction in Progressive Diabetic Nephropathy	4/47	2.990597937809684E-4	0.0013044417135772892	0	0	13.862563385207205	112.49285850166679	STAT5A;NFKBIA;IL1A;FOS
Negative Acute Phase Proteins Synthesis	4/48	3.2452527192411933E-4	0.0014014325175628636	0	0	13.546821599453178	108.82361125914723	NFKBIA;IL1A;IL1B;TNF
Gluten Impact on Neuronal System (Hypothesis)	4/48	3.2452527192411933E-4	0.0014014325175628636	0	0	13.546821599453178	108.82361125914723	NFKBIA;FOS;TICAM1;TNF
IL1R -> NF-kB Signaling	3/20	3.291166829116823E-4	0.0014142241622145558	0	0	26.136084284460054	209.58782672203765	NFKBIA;IL1A;IL1B
mTOR/NF-kB/BCR Signaling Disregulation in Mantle Cell Lymphoma	4/49	3.515073931052593E-4	0.0015029971291397293	0	0	13.245112781954887	105.34208812179386	NFKBIA;MIR17HG;TNFAIP3;TNF
Proteins Involved in Vitiligo	4/50	3.8005762975849497E-4	0.0016020260832840742	0	0	12.956521739130435	102.03504010982898	CSF2;TNF;DKK1;ICAM1
Conventional Dendritic Cell Role in Diabetes Mellitus Type 1	3/21	3.820499991241974E-4	0.0016020260832840742	0	0	24.682835820895523	194.25290764600277	NFKBIA;IL1B;TNF
IFN-gamma/TNF-alpha Mediated Cell Proliferation in Psoriasis	3/21	3.820499991241974E-4	0.0016020260832840742	0	0	24.682835820895523	194.25290764600277	NFKBIA;IRF1;TNF
IL17F Signaling in Bronchial Epithelial Cell in Asthma	3/21	3.820499991241974E-4	0.0016020260832840742	0	0	24.682835820895523	194.25290764600277	NFKBIA;CCL20;ICAM1
Diffuse Large-B-Cell Lymphoma	5/91	4.06557001628352E-4	0.001696593641410623	0	0	8.710799859055673	68.01206478937344	NFKBIA;NFKBIZ;MIR17HG;TNFAIP3;ICAM1
Hashimoto's Thyroiditis	4/51	4.102277528170341E-4	0.0017037210021300746	0	0	12.680211166213406	98.89040621581616	CXCL10;CXCL11;TNF;ICAM1
Proteins Involved in Astrocytoma	5/92	4.2758262039297183E-4	0.0017673414976242838	0	0	8.610240334378265	66.79275999923871	IL1B;IRF1;NPTX1;SOD2;TNF
Advanced Glycation End Products Pathway in Diabetic Microangiopathy	3/22	4.401628995495056E-4	0.0017847283410567772	0	0	23.382560879811468	180.70898085784813	NFKBIA;PLAU;ICAM1
Epithelial Cell in the Innate Immune Response in Ulcerative Colitis	3/22	4.401628995495056E-4	0.0017847283410567772	0	0	23.382560879811468	180.70898085784813	NFKBIA;FOS;TNF
Proteins with Altered Expression in Rheumatoid Arthritis	3/22	4.401628995495056E-4	0.0017847283410567772	0	0	23.382560879811468	180.70898085784813	CXCL8;IL1B;TNF
TNFR/NF-kB Alternative Pathway in Multiple Myeloma Plasma Cells	3/22	4.401628995495056E-4	0.0017847283410567772	0	0	23.382560879811468	180.70898085784813	IL1A;CXCL8;TNF
Myeloid Derived Suppressor Cells in Cancer Immune Escape	4/52	4.4206980798065337E-4	0.0017847283410567772	0	0	12.415413533834586	95.89718491598688	STAT5A;CSF3;CSF2;CSF1
Proteins with Altered Expression in Parkinson's Disease	2/5	4.595524823877063E-4	0.0018214226242581236	0	0	98.07407407407408	753.7245041531471	IL1B;TNF
Proteins with Altered Expression in Vitiligo	2/5	4.595524823877063E-4	0.0018214226242581236	0	0	98.07407407407408	753.7245041531471	CXCL8;ICAM1
Metabolism of Estrogens and Androgens	2/5	4.595524823877063E-4	0.0018214226242581236	0	0	98.07407407407408	753.7245041531471	CYP1A1;CYP1B1
TLR3 -> NF-kB Signaling	2/5	4.595524823877063E-4	0.0018214226242581236	0	0	98.07407407407408	753.7245041531471	NFKBIA;TICAM1
Proteins Involved in Pancreatic Cancer	5/94	4.7208388347701213E-4	0.0018625855039002114	0	0	8.415900578821928	64.45194475841807	CXCL8;IL1B;TNF;ICAM1;HSPA1A
Mucin Hyperproduction in Goblet and Mucous Cells	4/54	5.109791323191884E-4	0.002006922564945953	0	0	11.917593984962407	90.32561149667781	NFKBIA;IL1B;TICAM1;TNF
beta-Cell Destruction in Diabetes Mellitus Type 1	4/55	5.481516602630812E-4	0.0021432236085961913	0	0	11.683325961963734	87.72961045631041	NFKBIA;IL1B;IRF1;ICAM1
Lipoxins and Resolvins in Inflammation Resolution	3/24	5.727346328745557E-4	0.002209482939267175	0	0	21.15351812366738	157.9128757288317	CCL5;TNF;CX3CL1
Proteins Involved in Hashimoto's Thyroiditis	3/24	5.727346328745557E-4	0.002209482939267175	0	0	21.15351812366738	157.9128757288317	CXCL10;CD83;TNF
Lactate as a Signaling Molecule in Cancer Cells	3/24	5.727346328745557E-4	0.002209482939267175	0	0	21.15351812366738	157.9128757288317	NFKBIA;CXCL8;THBS1
T-Cell Independent B-Cell Activation	4/56	5.872065938369257E-4	0.0022453538477993458	0	0	11.45806824754193	85.24956144065452	STAT5A;NFKBIA;FOS;TICAM1
Crohn's Disease	4/56	5.872065938369257E-4	0.0022453538477993458	0	0	11.45806824754193	85.24956144065452	NFKBIA;IL1B;TICAM1;TNF
Synovial Fibroblast Proliferation in Rheumatoid Arthritis	4/57	6.281970139287871E-4	0.002391557053027137	0	0	11.241310824230387	82.87832583762037	STAT5A;IL1B;FOS;TNF
CD4+ T-Cell Function Decline in HIV	4/58	6.711761442269178E-4	0.002532960405169412	0	0	11.032581453634085	80.60932410457671	STAT5A;NFKBIA;IL23A;IL1B
Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma	4/58	6.711761442269178E-4	0.002532960405169412	0	0	11.032581453634085	80.60932410457671	NFKBIA;CCL5;TNFAIP3;CCL2
PTGER2/3 -> Inflammation-Related Expression Targets	3/26	7.283985897609024E-4	0.0027105710238062813	0	0	19.312134977287474	139.523650532531	STAT5A;CXCL8;FOS
Mitochondrial Dysfunction in Alzheimer's Disease	3/26	7.283985897609024E-4	0.0027105710238062813	0	0	19.312134977287474	139.523650532531	CYP1B1;SOD2;HSPA1A
OPTN Effects on NF-kB Signaling in Glaucoma	3/26	7.283985897609024E-4	0.0027105710238062813	0	0	19.312134977287474	139.523650532531	NFKBIA;TNFAIP3;TNF
Proteins Involved in Neuroblastoma	7/216	7.307299764639053E-4	0.0027105710238062813	0	0	5.0635995583364	36.56661486197232	CXCL10;CCL20;IL1B;CCL2;TNF;THBS1;CX3CL1
Proteins Involved in Multiple Myeloma	4/60	7.633140203045729E-4	0.0028193896579760394	0	0	10.6374865735768	76.35418781063395	IL1B;TNF;DKK1;ICAM1
Dectin-1 (CLEC7A) Signaling	3/27	8.153592497406877E-4	0.0029988636812496483	0	0	18.50652985074627	131.6162518017529	NFKBIA;CCL22;IL1B
VEGFA Dependent Angiogenesis in Cancer	4/62	8.64048097026319E-4	0.0031645305832018774	0	0	10.269639616282085	72.44082729745651	IL1A;IL1B;FOS;TNF
NF-kB non-Canonical Signaling	3/28	9.086467222529108E-4	0.003300022405504295	0	0	17.765373134328357	124.4207533401805	LTB;TNF;ICAM1
TNFRSF1A -> AP-1/ATF/TP53 Signaling	3/28	9.086467222529108E-4	0.003300022405504295	0	0	17.765373134328357	124.4207533401805	FOS;LTB;TNF
CD8+ T-Cell Response in Celiac Disease	4/63	9.177727164244848E-4	0.0033055050533462773	0	0	10.095068178921881	70.60047292379961	STAT5A;NFKBIA;FOS;ICAM1
IDO1 in Cancer Immune Escape	4/63	9.177727164244848E-4	0.0033055050533462773	0	0	10.095068178921881	70.60047292379961	NFKBIA;IL1B;IRF1;TNF
Natural Killer Cell Activation	4/65	0.0010322054249555725	0.0036639048952410375	0	0	9.763096265253298	67.13161204520495	STAT5A;IRF1;FOS;ICAM1
Proteins Involved in Diabetic Neuropathy	4/65	0.0010322054249555725	0.0036639048952410375	0	0	9.763096265253298	67.13161204520495	UNC13A;IL1B;TNF;HSPA1A
Th17-Cell Differentiation in Asthma	4/65	0.0010322054249555725	0.0036639048952410375	0	0	9.763096265253298	67.13161204520495	NFKBIA;IL23A;CCL20;IL1B
Proteins Involved in Dilated Cardiomyopathy	6/167	0.0010341667043019059	0.0036639048952410375	0	0	5.604855151486416	38.528667126415975	RCAN1;CSF3;CCL2;TICAM1;SOD2;TNF
Mast-Cell Related Chemokines Signaling in Asthma	3/30	0.00111489831728244	0.0039338688593543005	0	0	16.44776119402985	111.82819798488153	STAT5A;NFKBIA;CXCL10
Skin Fibrosis	4/67	0.0011563071876071395	0.004047075156624988	0	0	9.452201933404941	63.92074063922202	NFKBIA;CCL2;FOS;TNF
STAT3 and NFkB Activate Inflammation-Induced Tumorigenesis	4/67	0.0011563071876071395	0.004047075156624988	0	0	9.452201933404941	63.92074063922202	NFKBIA;IL1B;TNF;BIRC3
NFKB Non-Canonical Signaling Activation in Cancer	3/31	0.0012281995754051841	0.0042814346644646575	0	0	15.85954157782516	106.2939137967113	LTB;TNF;BIRC3
ADK Expression Downregulation after Acute Seizures	2/8	0.0012694971757935126	0.004390133659716211	0	0	49.02962962962963	326.9851886743162	IL1B;CCL2
Proteins with Altered Expression in Glomerulonephritis	2/8	0.0012694971757935126	0.004390133659716211	0	0	49.02962962962963	326.9851886743162	IL1B;TNF
Proteins Involved in Melanoma	7/238	0.0012846817898526754	0.004425015053936994	0	0	4.5762237762237765	30.465039309581375	CSF2;CXCL8;PLAU;ID1;FOS;SOD2;ETS1
Osteoclast Activation in Multiple Myeloma	4/69	0.0012905069068752076	0.004427509862322847	0	0	9.16043956043956	60.94184118303395	NFKBIA;CCL20;FOS;DKK1
Apoptosis Block in Infected Cells	3/32	0.0013485020417344183	0.004590195185197941	0	0	15.311888831703552	101.19261223612881	NFKBIA;TNF;BIRC3
TNF-alpha/TNFRSF1A Signaling	3/32	0.0013485020417344183	0.004590195185197941	0	0	15.311888831703552	101.19261223612881	NFKBIA;FOS;TNF
Cholesteatoma	4/70	0.0013615272880318104	0.0046164284609828575	0	0	9.02118933697881	59.532165405906404	NFKBIA;CSF2;CXCL8;TICAM1
Proteins Involved in Cystic Fibrosis	4/72	0.0015116759296353768	0.0050857934376880125	0	0	8.754975674480319	56.85950781773877	CXCL8;IL1B;CYP1A1;TNF
Proteins Involved in Systemic Lupus Erythematosus	4/72	0.0015116759296353768	0.0050857934376880125	0	0	8.754975674480319	56.85950781773877	CSF1;CCL2;TNF;ICAM1
Proteins Involved in Amyotrophic Lateral Sclerosis	6/181	0.0015620867126772938	0.0052351014154590385	0	0	5.1528026172300985	33.29603324686598	CSF2;PLAU;IL1B;CCL2;TNF;HSPA1A
Leukotriene Effect on Vascular Endothelial Cell Response	3/34	0.0016107379396855482	0.005336337907049831	0	0	14.32258064516129	92.10941640869986	NFKBIA;CXCL8;TNF
Natural Killer Cell Activation through ITSM-Containing Receptors	3/34	0.0016107379396855482	0.005336337907049831	0	0	14.32258064516129	92.10941640869986	CSF2;FOS;TNF
CCR5 Signaling in Macrophages	3/34	0.0016107379396855482	0.005336337907049831	0	0	14.32258064516129	92.10941640869986	CCL4;CCL2;FOS
Mitochondrial Respiratory Chain Dysfunction	2/9	0.0016248907120127863	0.005342443704648101	0	0	42.023280423280426	269.8867324286517	SOD2;HSPA1A
SNCA in Young Onset Parkinson's Disease	2/9	0.0016248907120127863	0.005342443704648101	0	0	42.023280423280426	269.8867324286517	PLK2;HSPA1A
Myocardial Infarction	4/74	0.0016729895525109187	0.0054798299304885945	0	0	8.503974221267454	54.36712413024341	NFKBIA;TICAM1;TNF;BIRC3
Natural Killer Cell Activation through C-Type Lectin-like Receptors	3/35	0.0017529746849877213	0.00569880908827469	0	0	13.874300373134329	88.0524303176085	CSF2;FOS;TNF
N2 Neutrophils in Tumor-Promoting Inflammation and Tumor Progression	3/35	0.0017529746849877213	0.00569880908827469	0	0	13.874300373134329	88.0524303176085	CCL5;IL1B;CCL2
Apoptosis Block in Synovial Fibroblast	3/36	0.001902819385173821	0.006117211949373617	0	0	13.453188602442333	84.27640498778267	NFKBIA;TNF;BIRC3
Estrogen Effects on Pregnancy Gingivitis	3/36	0.001902819385173821	0.006117211949373617	0	0	13.453188602442333	84.27640498778267	CXCL8;CCL2;FOS
ANGPT/TEK Maintains Endothelial Cell Quiescence in Cancer	3/36	0.001902819385173821	0.006117211949373617	0	0	13.453188602442333	84.27640498778267	NFKBIA;CXCL8;TNFAIP3
Proteins Involved in Hepatocellular Carcinoma	5/130	0.0020238371674427794	0.006482253362879456	0	0	5.981212121212121	37.10002318728297	STAT5A;FOS;SOD2;TNF;ICAM1
Basophil Activation	4/79	0.002127892668826805	0.006790481016697304	0	0	7.935037593984962	48.82129596795805	STAT5A;NFKBIA;TNF;HSPA1A
Blau Syndrome	3/38	0.0022258949896533445	0.007077204582487557	0	0	12.68315565031983	77.4635932754753	NFKBIA;IL1B;TICAM1
Aryl Hydrocarbon Receptor Genomic and non-Genomic Signaling	3/39	0.0023993972942811543	0.007573370368858334	0	0	12.330223880597014	74.38254041590923	STAT5A;CYP1A1;CYP1B1
TNFR -> AP-1/ATF/TP53 Signaling	3/39	0.0023993972942811543	0.007573370368858334	0	0	12.330223880597014	74.38254041590923	TNFSF14;FOS;TNF
Prostaglandin E2 Receptor Signaling in Neurons	2/11	0.0024602719008962578	0.007654179247232802	0	0	32.681481481481484	196.33345769415402	NFKBIA;IL1B
beta-Casomorphins/Opioid Receptors Affect Brain Function (Hypothesis)	2/11	0.0024602719008962578	0.007654179247232802	0	0	32.681481481481484	196.33345769415402	FOS;TNF
Dioxin Role in Endometriosis	2/11	0.0024602719008962578	0.007654179247232802	0	0	32.681481481481484	196.33345769415402	CYP1A1;CYP1B1
Aryl Hydrocarbon Receptor/Tryptophan Metabolites Signaling	2/11	0.0024602719008962578	0.007654179247232802	0	0	32.681481481481484	196.33345769415402	CYP1A1;CYP1B1
Proteins Involved in Noise-Induced Hearing Loss	3/40	0.0025810504679155263	0.008001256450538131	0	0	11.99636950383219	71.49306950229555	CSF3;TNF;HSPA1A
Proteins Involved in Epilepsy	7/270	0.002623169143344605	0.008102885467697926	0	0	4.012869260017549	23.849975182819474	IL1B;BDKRB2;CCL2;FOS;TNF;CX3CL1;HSPA1A
Proteins Involved in Glaucoma	4/84	0.002661752396276256	0.008192911631091454	0	0	7.437218045112782	44.09355952436512	CYP1B1;CCL2;TNF;HSPA1A
Peripheral Tolerance to Autoantigens Recession in Diabetes Mellitus Type 1	3/41	0.002770980696747608	0.008469053678791985	0	0	11.680086410054988	68.77881930842557	STAT5A;NFKBIA;FOS
Th17-Cell Activation in Crohn's Disease	3/41	0.002770980696747608	0.008469053678791985	0	0	11.680086410054988	68.77881930842557	STAT5A;CCL20;IL23A
Proteins Involved in Ulcerative Colitis	5/141	0.0028794576528320434	0.008769716640906013	0	0	5.494373885918003	32.14292961659983	CXCL8;CCL20;IL1B;TNF;ICAM1
Mast-Cell Activation without Degranulation through KIT/F2R Signaling	2/12	0.0029391057022227834	0.008827487022592995	0	0	29.411851851851853	171.4607999958469	NFKBIA;STAT5A
Androgen Receptor/NKX3-1 Signaling	2/12	0.0029391057022227834	0.008827487022592995	0	0	29.411851851851853	171.4607999958469	IL1B;TNF
MBP/MOG/PLP in Immune System Activation	2/12	0.0029391057022227834	0.008827487022592995	0	0	29.411851851851853	171.4607999958469	IL1A;TNF
IL23R -> STAT3/NF-kB Signaling	2/12	0.0029391057022227834	0.008827487022592995	0	0	29.411851851851853	171.4607999958469	NFKBIA;IL23A
Proteins Involved in Migraine	3/42	0.0029693104605084627	0.008887453378349468	0	0	11.380022962112514	66.22519605871695	ADM;TNF;ICAM1
Arterial Hypertension	3/44	0.0033916403126342913	0.009971740176089452	0	0	10.823807790316708	61.54895096050821	CXCL8;CCL2;FOS
CagA Phosphorylation Independent Signaling	3/44	0.0033916403126342913	0.009971740176089452	0	0	10.823807790316708	61.54895096050821	NFKBIA;CXCL8;CXCL1
T-Cells Differentiation Block in Psoriasis	3/44	0.0033916403126342913	0.009971740176089452	0	0	10.823807790316708	61.54895096050821	IL23A;IL1B;TNF
Treg Cells Promote Immunosuppression in Cancer Immune Escape	3/44	0.0033916403126342913	0.009971740176089452	0	0	10.823807790316708	61.54895096050821	STAT5A;NFKBIA;FOS
T-Cell Cytotoxic Response against Melanocytes in Vitiligo	4/90	0.0034155983339853586	0.009971740176089452	0	0	6.916244098618639	39.28013467233808	STAT5A;NFKBIA;CXCL8;IL1B
Advanced Glycation End Products in Diabetes or Age Related Erectile Dysfunction	2/13	0.0034579421578374717	0.009971740176089452	0	0	26.736700336700338	151.51906302862704	NFKBIA;SOD2
HMGB1/RAGE Signaling in Middle Ear Cholesteatoma	2/13	0.0034579421578374717	0.009971740176089452	0	0	26.736700336700338	151.51906302862704	NFKBIA;CXCL8
Proteins with Altered Expression in Gout	2/13	0.0034579421578374717	0.009971740176089452	0	0	26.736700336700338	151.51906302862704	CXCL8;IL1B
Ca2+ Cytosolic Overload	2/13	0.0034579421578374717	0.009971740176089452	0	0	26.736700336700338	151.51906302862704	NFKBIA;SOD2
STAT3 Facilitates the Function of Treg Cells and Cancer Progression	2/13	0.0034579421578374717	0.009971740176089452	0	0	26.736700336700338	151.51906302862704	STAT5A;IL23A
IL1R -> STAT3 Signaling	2/13	0.0034579421578374717	0.009971740176089452	0	0	26.736700336700338	151.51906302862704	IL1A;IL1B
Proteins Involved in Spontaneous Abortion	4/93	0.0038419701120795246	0.010989758894025373	0	0	6.682098504688688	37.164294959841726	IL1A;IL1B;LIF;TNF
Peripheral Tissue Microangiopathy	3/46	0.003848947815419025	0.010989758894025373	0	0	10.319333564734468	57.37503502498467	NFKBIA;PLAU;ICAM1
MERTK Signaling	3/46	0.003848947815419025	0.010989758894025373	0	0	10.319333564734468	57.37503502498467	CXCL8;FOS;TNF
Crystallin alpha B (CRYAB) Suppresses Multiple Sclerosis	2/14	0.004016218890047296	0.011355302920394307	0	0	24.507407407407406	135.21752237906108	NFKBIA;TNF
Oxidative Stress in Vitiligo	2/14	0.004016218890047296	0.011355302920394307	0	0	24.507407407407406	135.21752237906108	CXCL8;TNF
Glutamate Mediated Neurotoxicity	2/14	0.004016218890047296	0.011355302920394307	0	0	24.507407407407406	135.21752237906108	NFKBIA;SOD2
Bone Loss in Osteoporosis	3/48	0.004342084904701011	0.012157837733162829	0	0	9.859701492537313	53.63086674116421	STAT5A;TNF;DKK1
Diffuse Large-B-Cell Lymphoma ABC Subtype	3/48	0.004342084904701011	0.012157837733162829	0	0	9.859701492537313	53.63086674116421	NFKBIA;NFKBIZ;TNFAIP3
Proteins with Altered Expression in Cancer Immune Escape	3/48	0.004342084904701011	0.012157837733162829	0	0	9.859701492537313	53.63086674116421	CSF3;CSF2;TNF
Goblet-Cell Related Mucus Secretion in Asthma	3/49	0.0046023409106190965	0.012793652358070794	0	0	9.644873458792992	51.90089864584492	NFKBIA;IL1B;TNF
Longevity Related Drugs	2/15	0.004613379248935666	0.012793652358070794	0	0	22.62108262108262	121.67415851215912	BDKRB2;TNF
Glutamate Mediated Excitotoxicity in Amyotrophic Lateral Sclerosis	2/15	0.004613379248935666	0.012793652358070794	0	0	22.62108262108262	121.67415851215912	NFKBIA;SOD2
Proteins Involved in Parkinson's Disease	4/98	0.004630343508254803	0.012799803073774423	0	0	6.325067989121741	33.998026152786615	PLK2;IL1B;TNF;HSPA1A
Th17-Cell Function in Systemic Lupus Erythematosus	3/50	0.004871849321860696	0.013424651464682807	0	0	9.439187043505875	50.256890616051635	NFKBIA;IL23A;IL1B
Apoptosis Block by Death Receptor Signaling in Cancer	3/51	0.0051507016536939424	0.01414812985888083	0	0	9.242070895522389	48.69298109698855	NFKBIA;TNF;BIRC3
Paneth-Cell Function in Crohn's Disease	2/16	0.005248872260670303	0.014327110447364223	0	0	21.004232804232803	110.26680382213077	CXCL8;IL1B
MacrophageR -> CEBPB -> NF-kB Signaling	2/16	0.005248872260670303	0.014327110447364223	0	0	21.004232804232803	110.26680382213077	NFKBIA;ICAM1
Acute Cytotoxic CD8+T-Cell Response against Melanocytes	3/52	0.005438986235430609	0.014799498596720277	0	0	9.053000304599452	47.203815508814955	STAT5A;NFKBIA;FOS
T-Cell Acute Lymphoblastic Leukemia	4/103	0.005520936678178659	0.014975540739559612	0	0	6.004101161995899	31.216569263288722	STAT5A;NFKBIA;FOS;BIRC3
Mantle Cell Lymphoma	4/105	0.005907052556738403	0.01591463912966427	0	0	5.8846125214025164	30.197526417868914	NFKBIA;MIR17HG;TNFAIP3;TNF
Proteins Involved in Bronchiectasis	2/17	0.0059221525793566356	0.01591463912966427	0	0	19.602962962962962	100.54468078290444	IL1B;ICAM1
IFNLR1-> STAT/NFKB Signaling	2/17	0.0059221525793566356	0.01591463912966427	0	0	19.602962962962962	100.54468078290444	STAT5A;NFKBIA
Mast-Cells Activation in Atopic Dermatitis	3/54	0.006044189825406691	0.016192459161892	0	0	8.69710272168569	44.43052189846708	NFKBIA;CXCL8;TNF
FOXL2 Mutation in Ovarian Dysgenesis	2/18	0.006632680432496716	0.017552337242094967	0	0	18.376851851851853	92.17362609399046	TNFAIP3;SOD2
Proteins Involved in Antiphospholipid Syndrome	2/18	0.006632680432496716	0.017552337242094967	0	0	18.376851851851853	92.17362609399046	TICAM1;TNF
Oxidized LDL/OLR1 Activates Cell Proliferation in Cancer	2/18	0.006632680432496716	0.017552337242094967	0	0	18.376851851851853	92.17362609399046	NFKBIA;TNFAIP3
Myeloid Progenitor Cell -> GEMM - CFU Surface Expression Markers	2/18	0.006632680432496716	0.017552337242094967	0	0	18.376851851851853	92.17362609399046	CSF3;CSF2
Neutrophil Chemotaxis	3/56	0.006688104830893242	0.01759174240368283	0	0	8.368065333708815	41.902457284620134	CXCL8;CXCL2;CXCL5
Proteins Involved in B-Cell Chronic Lymphocytic Leukemia	3/56	0.006688104830893242	0.01759174240368283	0	0	8.368065333708815	41.902457284620134	TNFSF14;TNF;ICAM1
Neutrophil Activation via Adherence on Endothelial Cells	3/57	0.007024767448822506	0.018421444548573824	0	0	8.212686567164178	40.7210719480047	NFKBIA;CXCL8;ICAM1
Apoptosis of Thyroid Cell in Hashimoto's Thyroiditis	2/19	0.007379921577924611	0.019236552341256943	0	0	17.294989106753814	84.900967778125	IL1B;TNF
Genes with Mutations Associated with Psoriasis	2/19	0.007379921577924611	0.019236552341256943	0	0	17.294989106753814	84.900967778125	IL23A;TNF
Bone Remodeling in Hyperthyroidism	3/59	0.00772785401984002	0.02008316553659023	0	0	7.918576759061834	38.5074375378004	NFKBIA;CSF1;DKK1
Proliferative Diabetic Retinopathy	3/60	0.008094409868449698	0.02084054531823067	0	0	7.779261586802828	37.46944818368691	NFKBIA;PLAU;FOS
Th2-Cells Function in Systemic Scleroderma	3/60	0.008094409868449698	0.02084054531823067	0	0	7.779261586802828	37.46944818368691	STAT5A;NFKBIA;CCL2
Proteins Involved in Diabetes Mellitus Type 2	4/115	0.008108185099577295	0.02084054531823067	0	0	5.351757772810404	25.76807800179011	IL1B;CCL2;TNF;ICAM1
Dentin and Enamel Dysruprion in Bloch-Sulzberger Syndrome	2/20	0.008163347244468235	0.02084054531823067	0	0	16.333333333333332	78.53231621226735	LTB;TNF
Keratinocyte Proliferation in Acne Vulgaris	2/20	0.008163347244468235	0.02084054531823067	0	0	16.333333333333332	78.53231621226735	NFKBIA;IL1A
Proteins Involved in Vasospasm	2/20	0.008163347244468235	0.02084054531823067	0	0	16.333333333333332	78.53231621226735	ADM;TNF
CD8+ T-Cell Activation	3/62	0.008857855594311358	0.02254726878551982	0	0	7.514798886921326	35.51832552689539	STAT5A;NFKBIA;FOS
MTHFR Activity Regulation	2/21	0.008982434095061937	0.02259928346235873	0	0	15.4729044834308	72.91582063014043	NFKBIA;TNF
Glutamate Mediated Excitotoxicity in Glaucoma	2/21	0.008982434095061937	0.02259928346235873	0	0	15.4729044834308	72.91582063014043	NFKBIA;TNF
IL1B Induced Arthralgia	2/21	0.008982434095061937	0.02259928346235873	0	0	15.4729044834308	72.91582063014043	NFKBIA;IL1B
Dexamethasone Induced Osteoporosis	2/21	0.008982434095061937	0.02259928346235873	0	0	15.4729044834308	72.91582063014043	CSF1;DKK1
Natural Killer Cell Activation through ITAM-Containing Receptors	3/63	0.00925486088534575	0.02295205499565746	0	0	7.389179104477612	34.60061710207232	CSF2;FOS;TNF
T-Cell Dependent B-Cell Activation	3/63	0.00925486088534575	0.02295205499565746	0	0	7.389179104477612	34.60061710207232	STAT5A;NFKBIA;FOS
Th17-Cell Differentiation	3/63	0.00925486088534575	0.02295205499565746	0	0	7.389179104477612	34.60061710207232	NFKBIA;IL23A;IL1B
Basophil Activation in Asthma	3/63	0.00925486088534575	0.02295205499565746	0	0	7.389179104477612	34.60061710207232	STAT5A;NFKBIA;TNF
TLR2 Signaling in Treg-Cell in Type 1 Diabetes (Animal Model)	3/63	0.00925486088534575	0.02295205499565746	0	0	7.389179104477612	34.60061710207232	STAT5A;NFKBIA;TICAM1
Neutrophil Degranulation via FPR1/IL8	3/64	0.00966212697562637	0.023849789105325373	0	0	7.2676780034254955	33.718693496092364	NFKBIA;CXCL8;ICAM1
AGE Related Insulin Resistance in Skeletal Muscles	2/22	0.00983666417016876	0.023849789105325373	0	0	14.698518518518519	67.93124102556283	NFKBIA;BIRC3
Apoptosis of Chondrocyte	2/22	0.00983666417016876	0.023849789105325373	0	0	14.698518518518519	67.93124102556283	NFKBIA;TNF
CFTR Expression in Epithelial Cells (Class I Mutations)	2/22	0.00983666417016876	0.023849789105325373	0	0	14.698518518518519	67.93124102556283	NFKBIA;IL1B
MAVS in Antiviral Innate Immune Response in Myocarditis	2/22	0.00983666417016876	0.023849789105325373	0	0	14.698518518518519	67.93124102556283	NFKBIA;TICAM1
Cyclosporine Induced Nephrotoxicity	2/22	0.00983666417016876	0.023849789105325373	0	0	14.698518518518519	67.93124102556283	NFKBIA;CCL2
Doxorubicin Induced Cardiotoxicity	2/22	0.00983666417016876	0.023849789105325373	0	0	14.698518518518519	67.93124102556283	NFKBIA;SOD2
Estrogens/ESR1 Genomic Canonical Signaling	2/22	0.00983666417016876	0.023849789105325373	0	0	14.698518518518519	67.93124102556283	OXTR;FOS
B-Cell Activation in Systemic Lupus Erythematosus	3/65	0.010079704994237014	0.02430328870832702	0	0	7.1500962927298986	32.87064635491551	NFKBIA;FOS;BIRC3
Cardiomyocyte Hypertrophy	3/65	0.010079704994237014	0.02430328870832702	0	0	7.1500962927298986	32.87064635491551	NFKBIA;FOS;TNF
Th17-Cell and Th1 Immune Responsein Psoriatic Arthritis	3/66	0.010507643512664474	0.025264915703581064	0	0	7.036247334754798	32.054696586571794	NFKBIA;IL23A;IL1B
AHR Signaling in M1 Macrophages Function	2/23	0.010725524840857674	0.0256467095368167	0	0	13.997883597883598	63.48220615181043	NFKBIA;TNF
ICAM1 -> AP-1/CREB/ELK/SRF Signaling	2/23	0.010725524840857674	0.0256467095368167	0	0	13.997883597883598	63.48220615181043	FOS;ICAM1
T-Cell Maturation (Hypothesis)	3/68	0.01139478381780351	0.027172176796300674	0	0	6.8190585533869115	30.512556594459873	STAT5A;CXCL8;TNF
Proteins with Altered Expression in Asthma	2/24	0.011648508762921166	0.027701111249905676	0	0	13.360942760942761	59.49062791002039	CXCL10;CXCL8
B-Cells Function in Systemic Scleroderma	3/69	0.011854070338801651	0.02811293184174818	0	0	6.715400271370421	29.783364175421895	STAT5A;NFKBIA;FOS
Antiviral Signaling through Pattern Recognition Receptors	2/25	0.012605113827608986	0.029491209709877626	0	0	12.77938808373591	55.892605043800906	TICAM1;TNF
Blood-Brain Barrier Disruption in Epileptiform Disorders	2/25	0.012605113827608986	0.029491209709877626	0	0	12.77938808373591	55.892605043800906	IL1B;CCL2
ER Stress in Macular Degeneration	2/25	0.012605113827608986	0.029491209709877626	0	0	12.77938808373591	55.892605043800906	CXCL8;FOS
Proteins Involved in Sleep Disorders	2/25	0.012605113827608986	0.029491209709877626	0	0	12.77938808373591	55.892605043800906	IL1B;TNF
MTOR/TORC in Cancer Cell Motility and Invasion	2/25	0.012605113827608986	0.029491209709877626	0	0	12.77938808373591	55.892605043800906	PLAU;FOS
Humoral Immunity in Vitiligo	3/71	0.01280426995197287	0.029876629887936698	0	0	6.517230026338893	28.401935780117388	STAT5A;NFKBIA;FOS
Lymphocyte Mediated Myocardial Injury in Myocarditis	3/72	0.013295253532641238	0.030939088649685243	0	0	6.422452952628164	27.747232955177978	NFKBIA;IL23A;IL1B
Nitric Oxide Effects on beta-Cell	2/26	0.013594843115207917	0.031551667978610885	0	0	12.246296296296297	52.63537431715434	IL1B;HSPA1A
B-Cell Acute Lymphoblastic Leukemia	3/74	0.014309147336959262	0.03312090636928171	0	0	6.240908135379441	26.504239859629163	STAT5A;FOS;BIRC3
NTSR1 Expression Targets	2/27	0.01461720485208322	0.03356543336404295	0	0	11.755851851851851	49.67501067481879	CXCL8;FOS
Ketogenic Diet Mechanism (Hypothesis)	2/27	0.01461720485208322	0.03356543336404295	0	0	11.755851851851851	49.67501067481879	IL1B;TNF
Cancer Cells Inhibit Adipocyte Differentiation	2/27	0.01461720485208322	0.03356543336404295	0	0	11.755851851851851	49.67501067481879	NFKBIA;TNF
Proteins Involved in Prostate Cancer	4/138	0.015049063817330078	0.03446592979800134	0	0	4.428010324318258	18.58187740724703	STAT5A;PLAU;CCL2;ETS1
CFTR Related Ion-Channel Dysfunction in Cystic Fibrosis Airway Epithelium (Class III Mutations)	2/28	0.015671712356157393	0.03579749032932794	0	0	11.303133903133903	46.97467104492898	CXCL8;TNF
Complement Activation in Macular Degeneration	2/29	0.016757883997423763	0.03758615842316234	0	0	10.88395061728395	44.50323814745143	MASP2;CFB
Dystrophin Glycoprotein Complex Signaling in Muscular Dystrophies	2/29	0.016757883997423763	0.03758615842316234	0	0	10.88395061728395	44.50323814745143	NFKBIA;SOD2
IL6 Promotes Inflammation in Muscular Dystrophies	2/29	0.016757883997423763	0.03758615842316234	0	0	10.88395061728395	44.50323814745143	NFKBIA;FOS
Primary Mediastinal B-cell Lymphoma (PMBL) Subtype	2/29	0.016757883997423763	0.03758615842316234	0	0	10.88395061728395	44.50323814745143	NFKBIA;TNFAIP3
SOD1 Mutation	2/29	0.016757883997423763	0.03758615842316234	0	0	10.88395061728395	44.50323814745143	DNAJB1;HSPA1A
Vascular Endothelial Cell Vasodilation in Brain	2/29	0.016757883997423763	0.03758615842316234	0	0	10.88395061728395	44.50323814745143	NFKBIA;BDKRB2
TNFRSF1A -> CREB/ELK-SRF Signaling	2/29	0.016757883997423763	0.03758615842316234	0	0	10.88395061728395	44.50323814745143	LTB;TNF
Th0-Cell Aberrant Activation in Systemic Lupus Erythematosus	3/79	0.017031348398777606	0.03810105775809011	0	0	5.828849175176748	23.739151760115348	NFKBIA;FOS;TNF
Thrombopoietin Receptors Signaling in Platelet Maturation	2/30	0.017875243151028102	0.03968212546059435	0	0	10.494708994708995	42.234262373458584	STAT5A;FOS
Vitamin A (Retinol) Metabolism and Visual Cycle	2/30	0.017875243151028102	0.03968212546059435	0	0	10.494708994708995	42.234262373458584	CYP1A1;CYP1B1
Proteins Involved in Dental Caries	2/30	0.017875243151028102	0.03968212546059435	0	0	10.494708994708995	42.234262373458584	IL1B;TNF
Proteins Involved in Insulin Resistance	3/81	0.018195656921333334	0.04029038318295238	0	0	5.678817451205511	22.75259294703454	IL1B;CCL2;TNF
Acute Myeloid Leukemia	3/82	0.018794038066852117	0.041384060549208325	0	0	5.6066502928396	22.282036965286498	STAT5A;FOS;ICAM1
Vascular Endothelial Cell Activation by NO	2/31	0.01902331815568447	0.041384060549208325	0	0	10.132311621966794	40.14512833475264	NFKBIA;PLAU
Proteins Involved in Breast Cancer Related to NOTCH Signaling Pathway	2/31	0.01902331815568447	0.041384060549208325	0	0	10.132311621966794	40.14512833475264	NFKBIA;FOS
Proteins Involved in Prolactinoma	2/31	0.01902331815568447	0.041384060549208325	0	0	10.132311621966794	40.14512833475264	LIF;THBS1
Th17-Cell Numbers Reduction in HIV	2/31	0.01902331815568447	0.041384060549208325	0	0	10.132311621966794	40.14512833475264	IL23A;IL1B
Genes with Mutations in Cancer-Associated Resisting to Cell Death	2/31	0.01902331815568447	0.041384060549208325	0	0	10.132311621966794	40.14512833475264	NFKBIA;BIRC3
CD38/CD3 -> JUN/FOS/NF-kB Signaling in T-cell Proliferation	2/31	0.01902331815568447	0.041384060549208325	0	0	10.132311621966794	40.14512833475264	NFKBIA;FOS
NOD-like Receptors	2/32	0.02020164225783015	0.04351122947840339	0	0	9.794074074074073	38.216392592403565	IL1B;TICAM1
Endothelial Cell Dysfunction in Arterial Hypertension	2/32	0.02020164225783015	0.04351122947840339	0	0	9.794074074074073	38.216392592403565	BDKRB2;FOS
Glutamate Toxiicity Effects on Striatum Medium Spiny Neurons in Hantington's Disease	2/32	0.02020164225783015	0.04351122947840339	0	0	9.794074074074073	38.216392592403565	NFKBIA;SOD2
Estrogens/ESR1 non-Genomic Signaling	2/32	0.02020164225783015	0.04351122947840339	0	0	9.794074074074073	38.216392592403565	STAT5A;FOS
Hypertrophic Cardiomyopathy	3/89	0.02328642263581697	0.0500312248710127	0	0	5.148472752516487	19.357664485303136	NFKBIA;FOS;TNF
V(D)J Recombination Activation	2/35	0.023913514468541123	0.05125168039183628	0	0	8.902356902356903	33.23527158692459	STAT5A;NFKBIA
CD4+T-Cell Response in Celiac Disease	3/91	0.024667683364834898	0.052737805814474605	0	0	5.030953188602442	18.625903079979206	STAT5A;NFKBIA;IL1B
Dopamine Receptors Signaling	2/36	0.02520826423042625	0.05336773988295118	0	0	8.640087145969499	31.80056125985905	NFKBIA;FOS
Lipoxin A4/FPR2-Related Neutrophil Depression	2/36	0.02520826423042625	0.05336773988295118	0	0	8.640087145969499	31.80056125985905	CXCL8;FOS
Necrosis	2/36	0.02520826423042625	0.05336773988295118	0	0	8.640087145969499	31.80056125985905	TICAM1;TNF
WNT Signaling Activation by Blocking of Tumor Suppressors	2/36	0.02520826423042625	0.05336773988295118	0	0	8.640087145969499	31.80056125985905	FOS;DKK1
Lipolysis Regulation in Adipocyte	2/37	0.026531001534332275	0.05603140956642437	0	0	8.392804232804233	30.46119081340154	NFKBIA;TNF
CNR1/2 -> IL1B/2/4/6/10 Production	2/39	0.029258690661508067	0.06061227564245585	0	0	7.938338338338339	28.034866055627997	IL1B;FOS
Proteins Involved in Stem Cell Exhaustion in Aging	2/39	0.029258690661508067	0.06061227564245585	0	0	7.938338338338339	28.034866055627997	CXCL8;ID1
Hair Follicle Keratinocyte Apoptosis	2/39	0.029258690661508067	0.06061227564245585	0	0	7.938338338338339	28.034866055627997	TNF;DKK1
Podocyte Dysfunction in Diabetic Nephropathy	2/39	0.029258690661508067	0.06061227564245585	0	0	7.938338338338339	28.034866055627997	NFKBIA;TNF
PTPN22 Role in Rheumatoid Arthritis	2/39	0.029258690661508067	0.06061227564245585	0	0	7.938338338338339	28.034866055627997	NFKBIA;FOS
TRPM4/6/7/8 Signaling in Arterial Hypertension (Hypothesis)	2/39	0.029258690661508067	0.06061227564245585	0	0	7.938338338338339	28.034866055627997	STAT5A;FOS
Inhibition of THBS1 Activates Angiogenesis in Cancer	2/39	0.029258690661508067	0.06061227564245585	0	0	7.938338338338339	28.034866055627997	ID1;THBS1
CD38/CD19 -> JUN/FOS/NF-kB Signaling in B-cell Proliferation	2/39	0.029258690661508067	0.06061227564245585	0	0	7.938338338338339	28.034866055627997	NFKBIA;FOS
Interstitial Fibroblasts in Pyelonephritis	2/40	0.03066277991670126	0.06306941461539502	0	0	7.7290448343079925	26.93344690254291	FOS;TNF
Proteins Involved in Osteopetrosis	2/40	0.03066277991670126	0.06306941461539502	0	0	7.7290448343079925	26.93344690254291	CSF1;FOS
TNFR -> CREB/ELK-SRF Signaling	2/40	0.03066277991670126	0.06306941461539502	0	0	7.7290448343079925	26.93344690254291	TNFSF14;TNF
Club-Cell Role in Asthma	2/41	0.03209313151224259	0.06508607045006208	0	0	7.53048433048433	25.898188389601827	NFKBIA;TICAM1
Macrophage Dysfunction	2/41	0.03209313151224259	0.06508607045006208	0	0	7.53048433048433	25.898188389601827	IL1B;TNF
Mesangial Cell Dysfunction in Glomerulonephritis	2/41	0.03209313151224259	0.06508607045006208	0	0	7.53048433048433	25.898188389601827	FOS;TNF
Proteins Involved in Thrombophilia	2/41	0.03209313151224259	0.06508607045006208	0	0	7.53048433048433	25.898188389601827	IL1B;TNF
Proteins with Altered Expression in Endometriosis	2/41	0.03209313151224259	0.06508607045006208	0	0	7.53048433048433	25.898188389601827	IL1B;TNF
Megakaryocyte -> Platelet Precursor Cell Surface Expression Markers	2/41	0.03209313151224259	0.06508607045006208	0	0	7.53048433048433	25.898188389601827	CSF1;ICAM1
Acute Phase in Atopic Dermatitis	2/42	0.033549325462673474	0.0672642541494341	0	0	7.341851851851852	24.923667298432637	STAT5A;NFKBIA
Cowden Syndrome	2/42	0.033549325462673474	0.0672642541494341	0	0	7.341851851851852	24.923667298432637	STAT5A;FOS
Skeletal Muscle Wasting in Cancer Cachexia	2/42	0.033549325462673474	0.0672642541494341	0	0	7.341851851851852	24.923667298432637	NFKBIA;TNF
CHRNA7 -> IL8 Production	1/5	0.03378711383543003	0.0672642541494341	0	0	36.505514705882355	123.66884861369475	CXCL8
Androgen Receptor/c-Met Signaling in Prostate Cancer	1/5	0.03378711383543003	0.0672642541494341	0	0	36.505514705882355	123.66884861369475	ETS1
Proteins with Altered Expression in Osteoporosis	1/5	0.03378711383543003	0.0672642541494341	0	0	36.505514705882355	123.66884861369475	TNF
T-Cells Passage through the Blood-Brain Barrier	1/5	0.03378711383543003	0.0672642541494341	0	0	36.505514705882355	123.66884861369475	ICAM1
PECAM -> STAT Signaling	1/5	0.03378711383543003	0.0672642541494341	0	0	36.505514705882355	123.66884861369475	STAT5A
IGF1R/AKT Signaling in Breast Cancer	2/43	0.03503094623740955	0.06958091838460295	0	0	7.162420957542909	24.005021654272003	STAT5A;FOS
Apoptosis Evasion in Cancer: Overview	3/106	0.03640444042130974	0.07191524216150387	0	0	4.295029705839734	14.229710540140337	NFKBIA;TNF;BIRC3
Proteins with Altered Expression in Cancer Metastases	3/106	0.03640444042130974	0.07191524216150387	0	0	4.295029705839734	14.229710540140337	PLAU;ID1;FOS
Adiponectin Synthesis Declines in Insulin Resistance	2/44	0.03653758271108665	0.07191524216150387	0	0	6.991534391534391	23.137880991511924	FOS;TNF
beta-Cell Mass Regulation	2/44	0.03653758271108665	0.07191524216150387	0	0	6.991534391534391	23.137880991511924	STAT5A;FOS
Breast Cancer	3/108	0.03815119297305024	0.07492134728644255	0	0	4.212793176972282	13.759817707081377	STAT5A;NFKBIA;FOS
Proteins with Altered Expression in Melanoma	2/46	0.03962428004137379	0.07674735962546851	0	0	6.673063973063973	21.54274061714168	CXCL8;PLAU
Ras-GAP Regulation Signaling	2/46	0.03962428004137379	0.07674735962546851	0	0	6.673063973063973	21.54274061714168	IRF1;TNF
Brain Cell Necrosis in Vascular Dementia	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	SOD2
Genes with Mutations Associated with Cystic Fibrosis	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	CXCL8
Genes with Mutations Associated with Glomerulonephritis	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	CFB
Hemoglobin Reduction and Leukocyte Adhesion Initiate Vasospasm	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	ICAM1
Neurons Necrosis Caused by Energy Deficiency	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	SOD2
Proteins Involved in alpha 1-Antitrypsin Deficiency	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	TNF
Proteins with Altered Expression in Acne Vulgaris	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	IL1A
Proteins with Altered Expression in Erectile Dysfunction	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	SOD2
Oxidative Stress Protection via AHR-NFE2L2-NQO1 Signaling in Keratinocytes	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	CYP1A1
Aryl Hydrocarbon Receptor/Arachidonic Acid Metabolites Signaling	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	CYP1A1
KIT -> STAT Signaling	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	STAT5A
TLR3 -> IRF Signaling	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	TICAM1
TNFRSF5 -> STAT Signaling	1/6	0.040407308005575016	0.07674735962546851	0	0	29.20294117647059	93.70478036325976	STAT5A
Mucin Production in Goblet Airway Epithelial Cells	2/47	0.04120354031787479	0.07758063556597683	0	0	6.524444444444445	20.807961108127362	NFKBIA;TICAM1
Genes with Mutations in Cancer-Associated Evading of Growth Suppressors	2/47	0.04120354031787479	0.07758063556597683	0	0	6.524444444444445	20.807961108127362	NFKBIA;TNFAIP3
Proteins with Altered Expression in Cancer-Associated Resisting to Cell Death	2/47	0.04120354031787479	0.07758063556597683	0	0	6.524444444444445	20.807961108127362	NFKBIA;BIRC3
AXL Receptor Tyrosine Kinase Signaling	2/47	0.04120354031787479	0.07758063556597683	0	0	6.524444444444445	20.807961108127362	FOS;TNF
mTOR Signaling Hyperfunction	2/48	0.042806215056357025	0.0800771436830127	0	0	6.382286634460548	20.11104455243212	ID1;TNF
T-Cell Cytotoxic Mediated Cell Death	2/48	0.042806215056357025	0.0800771436830127	0	0	6.382286634460548	20.11104455243212	IRF1;ICAM1
T-Cell Cytotoxic Response in Ulcerative Colitis	2/48	0.042806215056357025	0.0800771436830127	0	0	6.382286634460548	20.11104455243212	NFKBIA;FOS
Skin Aging	2/49	0.04443191457135611	0.08276159194836288	0	0	6.246178092986604	19.449332300761156	FOS;TNF
Mesangial Cell Dysfunction in Diabetic Nephropathy	2/49	0.04443191457135611	0.08276159194836288	0	0	6.246178092986604	19.449332300761156	FOS;TNF
Natural Killer Cell in Diabetes Mellitus Type 1	2/50	0.046080253337353536	0.08528285692286326	0	0	6.1157407407407405	18.820401760879264	STAT5A;FOS
non-Suppressive Treg-Cell in Diabetes Mellitus Type 1	2/50	0.046080253337353536	0.08528285692286326	0	0	6.1157407407407405	18.820401760879264	STAT5A;NFKBIA
Proteins Involved in Hodgkin Lymphoma	2/50	0.046080253337353536	0.08528285692286326	0	0	6.1157407407407405	18.820401760879264	STAT5A;TNF
DCIR1 (CLEC4A) Signaling	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	TNF
Protein Oxidation and Aggregation in Aging	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	HSPA1A
Dysgenesis of the Anterior Segment of the Eye in Glaucoma	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	CYP1B1
Glutamate Role in Parkinson's Disease	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	NFKBIA
Proteins with Altered Expression in Androgenetic Alopecia	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	DKK1
Mitochondrial Damage Induced by Hypoxia	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	SOD2
CSF2 -> STAT Signaling	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	CSF1
IL4R -> STAT Signaling	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	STAT5A
UrokinaseR -> STAT Signaling	1/7	0.04698247325920365	0.0853154535334493	0	0	24.334558823529413	74.41461015948276	PLAU
Vascular Endothelial Cell Activation by Growth Factors	2/51	0.04775084997182041	0.0861699330052809	0	0	5.990627362055934	18.222041170234398	NFKBIA;ICAM1
ESR1 Signaling in Breast Cancer	2/51	0.04775084997182041	0.0861699330052809	0	0	5.990627362055934	18.222041170234398	STAT5A;FOS
Myocardial Remodeling	2/51	0.04775084997182041	0.0861699330052809	0	0	5.990627362055934	18.222041170234398	NFKBIA;FOS
Celiac Disease	2/52	0.04944332717711447	0.08867109088788298	0	0	5.8705185185185185	17.65222751068511	NFKBIA;TICAM1
VEGF Independent Angiogenesis in Cancer	2/52	0.04944332717711447	0.08867109088788298	0	0	5.8705185185185185	17.65222751068511	STAT5A;FOS
EGFR Signaling	2/52	0.04944332717711447	0.08867109088788298	0	0	5.8705185185185185	17.65222751068511	STAT5A;FOS
Metastatic Colorectal Cancer	3/121	0.050521896824585445	0.09041856998709313	0	0	3.7462054136099163	11.183728473172527	NFKBIA;CXCL8;ETS1
Adipokines and Cytokines in Insulin Resistance in Skeletal Muscles	2/53	0.05115731173617012	0.09136737980863306	0	0	5.755119825708061	17.109107109763784	TNF;CXCL5
Airway Smooth Muscle Cell High Rate Proliferation	2/54	0.05289243441829148	0.09327150335729811	0	0	5.644159544159544	16.590978573076498	STAT5A;FOS
ERBB/VEGFR/Akt Signaling in Breast Cancer	2/54	0.05289243441829148	0.09327150335729811	0	0	5.644159544159544	16.590978573076498	STAT5A;FOS
DC-SIGN (CD209) Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	NFKBIA
Oxytocin Action in Mammary Gland	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	OXTR
AngiopoietinR -> STAT Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	STAT5A
CD19 -> NF-kB Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	NFKBIA
CD2 -> STAT Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	STAT5A
HGFR -> STAT Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	STAT5A
IL10R -> STAT Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	STAT5A
IL21R -> STAT Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	STAT5A
IL31R -> STAT Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	STAT5A
IL9R -> STAT Signaling	1/8	0.05351291321651436	0.09327150335729811	0	0	20.857142857142858	61.06621624401382	STAT5A
Apoptosis and Immediate Early Gene Activation in Epileptiform Disorders	2/55	0.05464832999763346	0.09468014059470228	0	0	5.53738644304682	16.096277708168266	FOS;TNF
Proteins Involved in Breast Cancer Related to IGF1R/Akt Signaling Pathway	2/55	0.05464832999763346	0.09468014059470228	0	0	5.53738644304682	16.096277708168266	STAT5A;FOS
Th2-Cell Function in Systemic Lupus Erythematosus	2/55	0.05464832999763346	0.09468014059470228	0	0	5.53738644304682	16.096277708168266	STAT5A;NFKBIA
Th2-Cell Differentiation	2/57	0.058220998601404145	0.1000709441307303	0	0	5.3354882154882155	15.17150976644115	STAT5A;NFKBIA
Prolactinoma Overiew	2/57	0.058220998601404145	0.1000709441307303	0	0	5.3354882154882155	15.17150976644115	LIF;FOS
Th2-Cell Response in Asthma	2/57	0.058220998601404145	0.1000709441307303	0	0	5.3354882154882155	15.17150976644115	STAT5A;NFKBIA
Treg-Cell Activation in Diabetes Mellitus	2/57	0.058220998601404145	0.1000709441307303	0	0	5.3354882154882155	15.17150976644115	STAT5A;NFKBIA
DRD2 -> TRPC1 Transcription	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	NFKBIA
Leptin -> CD25/IL6/IL10 Production	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	STAT5A
MIR155 Role in Th17-Cell in Multiple Sclerosis	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	NFKBIA
IGF1R -> STAT Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	STAT5A
IL12R -> STAT Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	STAT5A
IL13R -> STAT Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	STAT5A
IL3R -> STAT Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	STAT5A
IL5R -> STAT Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	STAT5A
IL7R -> STAT Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	STAT5A
InsulinR -> STAT Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	STAT5A
NOTCH -> NF-kB Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	NFKBIA
TGFBR3 -> ARRB2 Signaling	1/9	0.059998929586478865	0.10021570911700597	0	0	18.249080882352942	51.34248529605202	NFKBIA
Treg-Cell Differentiation	2/58	0.06003706076133998	0.10021570911700597	0	0	5.23994708994709	14.738887690151744	STAT5A;NFKBIA
Effector T-cell Inactivation in Cancer Immune Escape	2/58	0.06003706076133998	0.10021570911700597	0	0	5.23994708994709	14.738887690151744	NFKBIA;TNF
Proteins with Altered Expression in Cancer-Associated Evading of Growth Suppressors	2/58	0.06003706076133998	0.10021570911700597	0	0	5.23994708994709	14.738887690151744	NFKBIA;TNFAIP3
Mucinous Ovarian Carcinoma	2/60	0.06372689242803448	0.10596732304125274	0	0	5.05874840357599	13.927486248806423	STAT5A;FOS
Proteins Involved in Female Infertility	2/60	0.06372689242803448	0.10596732304125274	0	0	5.05874840357599	13.927486248806423	CSF1;LIF
Bone Resorption by Osteoclasts in Osteoporosis	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	TNF
HMGB1 and IL1B in Neuronal Hyperexcitation	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	IL1B
WNT Inhibition by DKK1 in Osteoblast in Multiple Myelome	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	DKK1
AGER -> NF-kB Signaling	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	NFKBIA
HCAR1/HCAR2 -> MAPK Signaling	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	TNF
IFNG -> ARRB1/STAT1 Signaling	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	STAT5A
IL12R -> NF-kB/NFATC Signaling	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	NFKBIA
IL2R -> STAT Signaling	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	STAT5A
ProlactinR -> STAT Signaling	1/10	0.06644082214506918	0.10860759627480233	0	0	16.220588235294116	43.98121048429159	STAT5A
Treg-Cell Function in Diabetes Mellitus Type 1	2/62	0.06749138031716871	0.11011751525432789	0	0	4.8896296296296295	13.181245420683382	STAT5A;NFKBIA
Proteins Involved in Hypothyroidism	2/63	0.0694007767375199	0.11280875319881513	0	0	4.80922890103218	12.830336043119242	IL1B;TNF
EGFR Transactivation in Cancer and Non-Cancer Cells	2/63	0.0694007767375199	0.11280875319881513	0	0	4.80922890103218	12.830336043119242	CXCL8;BDKRB2
Proteins Involved in Breast Cancer Related to ESR1 Signaling Pathway	2/64	0.07132783226986396	0.11542701736986671	0	0	4.73142174432497	12.493170896128214	STAT5A;FOS
Alstrom Syndrome Progression (Hypothesis)	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	HAP1
EGF/cyclinD1 Signaling in Acquired Middle Ear Cholesteatoma	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	NFKBIA
EPHA2 Mutations in Cataract	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	NFKBIA
Hashimoto's Thyroiditis Triggers	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	ICAM1
Hexosamine Pathway in Diabetic Microangiopathy	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	PLAU
Metals and Amyloid beta Toxicity in Alzheimer's Disease	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	FOS
Periostin (POSTN) Production by Airway Epithelium in Asthma	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	FOS
Proteins Involved in Ependymoma	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	CXCL8
Tricarboxylic Acid Cycle Enzymes Involvement in Alzheimer Disease	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	HSPA1A
IL15R -> NF-kB/NFATC Signaling	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	NFKBIA
IL15R -> STAT Signaling	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	STAT5A
TGFBR1/AP-1 Signaling	1/11	0.07283888870776588	0.11542701736986671	0	0	14.597794117647059	38.23899878007725	FOS
Clear Cell Endometrial Cancer and Papillary Serous Endometrial Cancer	2/65	0.07327221955160894	0.11542701736986671	0	0	4.656084656084656	12.169020581349075	STAT5A;FOS
HPV Infection and Cancer	2/65	0.07327221955160894	0.11542701736986671	0	0	4.656084656084656	12.169020581349075	FOS;TNF
Natural Killer T-Cell Roles in Diabetes Mellitus Type 1	2/65	0.07327221955160894	0.11542701736986671	0	0	4.656084656084656	12.169020581349075	STAT5A;NFKBIA
Proteins Involved in Hypertrophic Cardiomyopathy	2/65	0.07327221955160894	0.11542701736986671	0	0	4.656084656084656	12.169020581349075	FOS;TNF
Platelet Activation via Adhesion Molecules	2/66	0.07523361480001642	0.11830213341741713	0	0	4.583101851851852	11.857204691208892	CXCL8;TNF
Alzheimer's Disease	2/67	0.07721169783815038	0.12119304470798287	0	0	4.512364672364672	11.557087833747978	IL1B;TNF
Mast-Cell Activation without Degranulation through CYSLTR1/CYSLTR2 Signaling	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	CXCL8
Androgen Receptor/Prostate Specific Antigen Signaling in Prostate Cancer	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	SERPINA3
Hyper IgM Syndrome	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	NFKBIA
nNOS (NOS1) and iNOS (NOS2) Activation via Glutamate	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	NFKBIA
Proteins with Altered Expression in Systemic Scleroderma	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	CCL2
Dioxin Induced Chloracne (Hypothesis)	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	IL1B
Telomeric Proteins/NFKB Positive Feedback Interplay in Cancer	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	NFKBIA
DDR1 -> NF-kB Signaling	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	NFKBIA
EctodysplasinR -> NF-kB Signaling	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	NFKBIA
IL7R -> FOXO/NF-kB Signaling	1/12	0.07919342514991488	0.12189882962755672	0	0	13.270053475935828	33.65102433952089	NFKBIA
Proteins Involved in Primary Ovarian Insufficiency	2/68	0.07920615196997925	0.12189882962755672	0	0	4.443771043771044	11.26807604276484	CITED2;NANOS3
Chronic Myeloid Leukemia	2/70	0.08324292430835176	0.12720925756980514	0	0	4.312636165577342	10.721179640609002	STAT5A;FOS
Dilated Cardiomyopathy	2/70	0.08324292430835176	0.12720925756980514	0	0	4.312636165577342	10.721179640609002	NFKBIA;TNF
Growth Factor Signaling in Pancreatic Neoplasms	2/70	0.08324292430835176	0.12720925756980514	0	0	4.312636165577342	10.721179640609002	STAT5A;FOS
Low-Grade Serous Ovarian Carcinoma	2/70	0.08324292430835176	0.12720925756980514	0	0	4.312636165577342	10.721179640609002	STAT5A;FOS
BDKRB1/2 -> Vasodilation	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	BDKRB2
Protein Folding	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	HSPA1A
Ammonia Effects on Brain Cells	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	NFKBIA
Proteins Involved in Marginal Zone Lymphoma	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	BIRC3
Proteins Involved in Werner Syndrome (Adult Progeria)	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	ICAM1
Retinoic Acid Role in Endometriosis	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	CYP1B1
VEGFA Low Expression Level in Chronic Bronchitis	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	FOS
B-Cell Differentiation Inhibition by Dioxin	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	CYP1A1
FGFR1 -> STAT Signaling	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	STAT5A
TLR1/2/6 -> NF-kB Signaling	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	NFKBIA
TLR4 -> IRF Signaling	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	TICAM1
TLR4/5/7/9 -> NF-kB Signaling	1/13	0.08550472536145746	0.12796224416162946	0	0	12.163602941176471	29.912533322109574	NFKBIA
Proteins Involved in Breast Cancer Related to ERBB2/VEGFR/Akt Signaling Pathway	2/72	0.08734146782854477	0.13026184548999462	0	0	4.188994708994709	10.212475557360575	STAT5A;FOS
Th1-Cells Activation and Proliferation in Atherosclerosis	2/72	0.08734146782854477	0.13026184548999462	0	0	4.188994708994709	10.212475557360575	STAT5A;NFKBIA
Complement Activation by Lectin	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	MASP2
Complement Alternative Pathway	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	CFB
Mast-Cell Activation without Degranulation through IL33/IL1RL1 Signaling	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	NFKBIA
Melatonin in Cell Survival and Antioxidant Response	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	FOS
PRL and CSH Action in Mammary Gland	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	STAT5A
SCF/FBXO7 Complex	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	NFKBIA
Genes with Mutations Associated with Atopic Dermatitis	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	CCL5
Neurotoxin Effects in Parkinson's Disease	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	SOD2
NOTCH Signaling in Multiple Myeloma	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	CXCL8
Protein Kinase C in Diabetic Microangiopathy	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	NFKBIA
Proteins Involved in Sleep Initiation and Maintenance Disorders	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	IL1B
Proteins Involved in Urolithiasis	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	PLAU
FGFR3 -> STAT Signaling	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	STAT5A
NGFR -> NF-kB Signaling	1/14	0.09177308130260607	0.13365609827292294	0	0	11.22737556561086	26.815870864611973	NFKBIA
Glioma Invasion Signaling	2/75	0.09359984778135792	0.13586064861909478	0	0	4.0162354134956875	9.513363341608922	PLAU;FOS
Integrins in Cancer Cell Motility, Invasion and Survival	2/75	0.09359984778135792	0.13586064861909478	0	0	4.0162354134956875	9.513363341608922	FOS;THBS1
Endometrioid Ovarian Carcinoma	2/76	0.09571428355567489	0.13869782658819	0	0	3.9617617617617618	9.295829219487588	STAT5A;FOS
Apoptosis	2/77	0.09784239395805285	0.13944744856132532	0	0	3.9087407407407406	9.085466501614851	TNF;BIRC3
Histidine-Rich Glycoprotein (HRG)	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	THBS1
Immunoglobulin Genes Transcriptional Activation	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	STAT5A
N-cell: Neurotensin Production	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	FOS
KISS1 Production Impairment in Hypogonadotropic hypogonadism	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	FOS
Mitochondria Enlargement and Apoptosis in Alzheimer's Disease	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	HSPA1A
NO Synthesis in Early Vasospasm	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	NFKBIA
TRPM8 Effects in Prostate Cancer (Hypothesis)	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	FOS
WNT Signaling in Hepatocellular Carcinoma	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	FOS
EphrinR -> STAT Signaling	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	STAT5A
MTNR1 Signaling	1/15	0.09799878297512493	0.13944744856132532	0	0	10.424894957983193	24.214948291558056	FOS
Natural Killer Cell Precursor -> Natural Killer Cell Surface Expression Markers	2/78	0.09998389586964657	0.14203931524525895	0	0	3.8571150097465887	8.881956728256293	STX11;ICAM1
BDKRB1/2 -> Ion Channels	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	BDKRB2
Dectin-2 (CLEC6A)/Mincle (CLEC4E)/BDCA2 (CLEC4C) Signaling	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	TNF
Aminoglycosides and Cisplatin Induced Ototoxicity (Mouse Model)	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	TNF
DRD2 Pharmacological Inhibition in Hyperprolactinemia	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	FOS
Fatty Acid Synthase (FASN) Signaling	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	STAT5A
Genes with Mutations Associated with Glaucoma	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	CYP1B1
Hypothyrodism Associated Hyperprolactinemia	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	FOS
NKX2-1 in Thyroid Dysgenesis (Hypothesis)	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	HSPA1A
NO Effect on Vasodilation and Vasoconstriction	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	RGS2
Proteins Involved in Vascular Dementia	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	TNF
TGFBR -> AP-1 Signaling	1/16	0.10418211846622599	0.14538597882425106	0	0	9.729411764705882	22.004181371864657	FOS
Atopic Dermatitis	2/81	0.10648596701875793	0.148124710532503	0	0	3.7100796999531176	8.309621578120886	STAT5A;NFKBIA
Clear Cell Ovarian Carcinoma	2/81	0.10648596701875793	0.148124710532503	0	0	3.7100796999531176	8.309621578120886	STAT5A;FOS
Growth Factor Signaling in Hepatocellular Carcinoma	2/82	0.10867826700902473	0.1506912711882324	0	0	3.6635185185185186	8.130679063097565	STAT5A;FOS
High-Grade Serous Ovarian Carcinoma	2/82	0.10867826700902473	0.1506912711882324	0	0	3.6635185185185186	8.130679063097565	STAT5A;FOS
Toll-like Receptors Act through MYD88 Signaling	1/17	0.11032337391025118	0.15152007682610447	0	0	9.120863970588236	20.1054803872225	NFKBIA
IL33 Signaling Related Eosinophilia in Asthma	1/17	0.11032337391025118	0.15152007682610447	0	0	9.120863970588236	20.1054803872225	NFKBIA
PGF2-alpha Effect on Treatment	1/17	0.11032337391025118	0.15152007682610447	0	0	9.120863970588236	20.1054803872225	FOS
Dexamethasone Induced Neurotoxicity	1/17	0.11032337391025118	0.15152007682610447	0	0	9.120863970588236	20.1054803872225	DKK1
Ethanol Induced Hepatotoxicity	1/17	0.11032337391025118	0.15152007682610447	0	0	9.120863970588236	20.1054803872225	SOD2
FibronectinR -> NF-kB Signaling	1/17	0.11032337391025118	0.15152007682610447	0	0	9.120863970588236	20.1054803872225	NFKBIA
Proteins with Altered Expression in Cancer Metabolic Reprogramming	2/85	0.11532625072762334	0.15814089357279157	0	0	3.5305667112896026	7.625989512204862	CXCL8;TNF
FOXA2 Signaling in Prostate Cancer	1/18	0.11642283357542343	0.1588915401626848	0	0	8.583910034602075	18.459926845841217	ADM
PARK2/PINK1/UCHL1 in Young Onset Parkinson's Disease	1/18	0.11642283357542343	0.1588915401626848	0	0	8.583910034602075	18.459926845841217	HSPA1A
Monoblast -> Promonocyte Surface Expression Markers	1/18	0.11642283357542343	0.1588915401626848	0	0	8.583910034602075	18.459926845841217	TNF
DRD1/5 Expression Targets	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	FOS
Apoptosis of Myocyte	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	TNF
Axonal Transport Impairment in Hungtington Disease	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	HAP1
Osteoclasts Function in Osteopetrosis	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	NFKBIA
PPARGC1A Repression in Huntington Disease	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	SOD2
SOCS in Negative Feedback Regulation in Myocarditis	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	TNF
ANGPT/TEK Stimulates Endothelial Cell Migration in Cancer	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	FOS
FBLN5 Potentiates Migration and Proliferation of Endothelial Cells in Cancer	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	THBS1
Proteins with Altered Expression in Cancer-Associated Enabling of Replicative Immortality	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	ETS1
B-Cell Receptor -> NF-kB Signaling	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	NFKBIA
EctodysplasinR -> AP-1 Signaling	1/19	0.12248077981539765	0.1643173367538874	0	0	8.106617647058824	17.022285145241106	FOS
HTR5 -> TNF Production	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	TNF
P2RY11/13/14 -> IL8/10 Production	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	CXCL8
Vascular Smooth Muscle Cell/Pericyte Differentiation and Proliferation	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	ID1
Mitochondrial Protein Transport	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	HSPA1A
alpha-Cell to beta-Cell Interconversion (Hypothesis)	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	MAFB
Complement Activation in Glomerulonephritis	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	CFB
Ethanol Induced Efects in Hyperprolactinemia	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	FOS
Genes with Mutations Associated with Asthma	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	TNF
Goblet-Cell Exocytosis in Asthma	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	HSPA1A
Proteins Involved in Hyperprolactinemia	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	LIF
Apoptosis Block by Inhibitor of Apoptosis Proteins (IAPs) in Cancer	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	BIRC3
EGFR/ERBB -> STAT Signaling	1/20	0.1284974930534796	0.1692501122464648	0	0	7.679566563467493	15.757287045296094	STAT5A
Endometrioid Endometrial Cancer	2/92	0.13121988305093643	0.17257402801244368	0	0	3.254814814814815	6.610141130789733	STAT5A;FOS
ESR1/ERBB Positive Luminal Breast Cancer	2/93	0.13353037973332157	0.1742131083767034	0	0	3.2188848188848187	6.48098723347588	STAT5A;FOS
ECL-cell: CHGA and Histamine Synthesis	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	CXCL8
CCL2 Role in CGRP Expression and Release	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	CCL2
EGFR and PTAFR Signaling in Ovarian Cancer	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	PTAFR
FSH Action in Polycystic Ovary Syndrome	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	FOS
MUC5AC Expression by NTHi and S. Pneumoniae	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	FOS
Proteins Involved in Autistic Disorder and Aggression	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	OXTR
RET1 Mutation in Hyperparathyroidism	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	NFKBIA
Dexamethasone Induced Diabetes	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	DKK1
B-Cell Receptor -> AP-1 Signaling	1/21	0.13447325185759362	0.1742131083767034	0	0	7.295220588235294	14.637057422023762	FOS
Proteins with Altered Expression in Aging	1/22	0.14040833300105676	0.18028762284751074	0	0	6.947478991596639	13.639293794381585	TNF
EGFR Nuclear Signaling in Colorectal Cancer	1/22	0.14040833300105676	0.18028762284751074	0	0	6.947478991596639	13.639293794381585	STAT5A
Lymphoma, GCB Subtype	1/22	0.14040833300105676	0.18028762284751074	0	0	6.947478991596639	13.639293794381585	MIR17HG
Proteins Involved in Celiac Disease	1/22	0.14040833300105676	0.18028762284751074	0	0	6.947478991596639	13.639293794381585	TNF
Proteins Involved in Photoaging	1/22	0.14040833300105676	0.18028762284751074	0	0	6.947478991596639	13.639293794381585	TNF
CD19 -> JUN/ELK Signaling	1/22	0.14040833300105676	0.18028762284751074	0	0	6.947478991596639	13.639293794381585	FOS
Proteins Involved in Polycystic Kidney Disease	2/97	0.14286280257367737	0.1831682609068714	0	0	3.082729044834308	5.998591605942089	CCL2;TNF
Proteins Involved in Huntington Disease	2/98	0.14521737323047415	0.18351302569326763	0	0	3.050462962962963	5.885940074806264	RCAN1;HAP1
AHR Signaling in Treg and Dendritic Cells Function	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	STAT5A
Eicosanoids in Myeloid Cell Activation	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	NFKBIA
Neutrophil Activation via LTB4/Polyisoprenyl Phosphate Signaling	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	FOS
Somatostatin Receptors Signaling	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	TNF
Angiotensin-Aldosterone System Activation Scheme	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	FOS
Complement System Defects in Systemic Lupus Erythematosis	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	MASP2
Hodgkin and Reed-Sternberg Cells Reprogramming	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	STAT5A
Proteins Involved in Chronic Myeloid Leukemia	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	STAT5A
Telogen Maintenance in Androgenic Alopecia	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	DKK1
Transcription Factors in beta-Cell Neogenesis (Rodent Model)	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	MAFB
Hypoxia-Induced Cell Death Evasion in Cancer	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	BIRC3
ActivinR -> SMAD2/3 Signaling	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	INHBC
UrokinaseR -> ELK/SRF Signaling	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	PLAU
WNT Planar Cell Polarity (PCP) non-Canonical Signaling	1/23	0.14630301126698295	0.18351302569326763	0	0	6.63135026737968	12.745955140425728	FOS
Proteins Involved in Male Infertility	3/193	0.14667149760036677	0.18370975457015637	0	0	2.3181068342498037	4.449744930118893	NANOS3;GAPDHS;HSPA1A
Proteins Involved in Colorectal Neoplasms	2/99	0.1475800815835904	0.1845814276866808	0	0	3.0188621611302024	5.776243537061962	CXCL8;TNF
Androgen Deficiency in Male Obesity	1/24	0.15215755971727135	0.18867537404941648	0	0	6.342710997442455	11.942301842584483	TNF
Apoptosis of Cochlear Hair Cells (Noise-Induced, Mouse Model)	1/24	0.15215755971727135	0.18867537404941648	0	0	6.342710997442455	11.942301842584483	SOD2
beta-Cell Granules Exocytois	1/24	0.15215755971727135	0.18867537404941648	0	0	6.342710997442455	11.942301842584483	UNC13A
NOTCH Signaling in Hepatocellular Carcinoma	1/24	0.15215755971727135	0.18867537404941648	0	0	6.342710997442455	11.942301842584483	FOS
Proteins Involved in Hypoxia-Induced Pulmonary Hypertension	1/24	0.15215755971727135	0.18867537404941648	0	0	6.342710997442455	11.942301842584483	ID1
TLR -> AP-1 Signaling	1/24	0.15215755971727135	0.18867537404941648	0	0	6.342710997442455	11.942301842584483	FOS
AHR Signaling in Th17 Cells Function	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	STAT5A
Eat me Signal: Apoptotic Cell Initiates Phagocytosis	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	THBS1
Leptin and CCK8 Activate Nodose Ganglia Neuron	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	FOS
Axonal Transport	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	HAP1
Alveolar Epithelial Cell Apoptosis in COPD	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	TNF
Enterocyte Mediated Mucosal Damage in Celiac Disease	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	NFKBIA
Genes with Mutations Associated with Age-Related Macular Degeneration	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	CFB
Hereditary Hemorrhagic Telangiectasia	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	ID1
Local Estrogen Production in Endometriosis	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	IL1B
SERPINA1 Associated Liver Damage	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	CXCL8
Sialophorin -> CTNNB/MYC/TP53 Signaling	1/25	0.15797224953081032	0.19285501067896393	0	0	6.078125	11.216182250545017	ICAM1
Medulloblastoma	2/104	0.15950809433469024	0.19445649702599876	0	0	2.8701525054466233	5.268625898553727	CCL5;ID1
BDKRB1/2 -> Prostaglandin Generation	1/26	0.16374735008097807	0.1979564065045807	0	0	5.834705882352941	10.557495291482919	BDKRB2
Melatonin Effects on Circadian Cycle	1/26	0.16374735008097807	0.1979564065045807	0	0	5.834705882352941	10.557495291482919	FOS
SIRT3 Signaling in Aging	1/26	0.16374735008097807	0.1979564065045807	0	0	5.834705882352941	10.557495291482919	SOD2
Endothelial Cell Dysfunction in Progressive Diabetic Nephropathy	1/26	0.16374735008097807	0.1979564065045807	0	0	5.834705882352941	10.557495291482919	FOS
GUCY2C Signaling in Colorectal Cancer	1/26	0.16374735008097807	0.1979564065045807	0	0	5.834705882352941	10.557495291482919	FOS
CD157/ITGB2 Signaling in Myeloid Cell	1/26	0.16374735008097807	0.1979564065045807	0	0	5.834705882352941	10.557495291482919	NFKBIA
Endometrial Cancer	2/106	0.16432877560455972	0.1983830003125978	0	0	2.8146723646723646	5.0829777800563765	STAT5A;FOS
IL6 Expression Targets -> Nociception	1/27	0.16948312893832804	0.20235399713682084	0	0	5.610011312217194	9.957780689975772	CXCL8
Peroxisome Protein Import and Peroxisome Division	1/27	0.16948312893832804	0.20235399713682084	0	0	5.610011312217194	9.957780689975772	HSPA1A
Endothelin Signaling in Arterial Hypertension	1/27	0.16948312893832804	0.20235399713682084	0	0	5.610011312217194	9.957780689975772	FOS
MIF Role in Cholesteatoma	1/27	0.16948312893832804	0.20235399713682084	0	0	5.610011312217194	9.957780689975772	NFKBIA
Oxidation of Fatty Acid in non-Alcoholic Fatty Liver Disease	1/27	0.16948312893832804	0.20235399713682084	0	0	5.610011312217194	9.957780689975772	TNF
Reperfusion Injury in Myocardial ischemia	1/27	0.16948312893832804	0.20235399713682084	0	0	5.610011312217194	9.957780689975772	HSPA1A
WNT Canonical Signaling Activation in Cancer	1/27	0.16948312893832804	0.20235399713682084	0	0	5.610011312217194	9.957780689975772	FOS
ActivinR/BMPR -> SMAD1/5/9 Signaling	1/27	0.16948312893832804	0.20235399713682084	0	0	5.610011312217194	9.957780689975772	INHBC
Proteins Involved in Hearing Loss	3/209	0.17297527531517723	0.2062397513373267	0	0	2.1363208230691204	3.748402641406349	IL1B;FSCN2;TNF
Hypothyroidism, Secondary (Central)	1/28	0.1751798518463186	0.2080110963099925	0	0	5.401960784313726	9.409902955799433	STAT5A
Postsynaptic Neuron Activation	1/28	0.1751798518463186	0.2080110963099925	0	0	5.401960784313726	9.409902955799433	NFKBIA
ERBB2/3 -> EP300/ETS/ETV/SP1 Signaling	1/28	0.1751798518463186	0.2080110963099925	0	0	5.401960784313726	9.409902955799433	ETS1
Hepatocellular Carcinoma	2/112	0.17893937908653246	0.2118315728428783	0	0	2.6603367003367	4.577663161255457	STAT5A;FOS
AHR Signaling in Tr1 Cells Function	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	NFKBIA
Autophagic-Lysosomal System Decline Associated with Aging	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	HSPA1A
Eat me Signal: Apoptotic Cell Induces Phagocytosis	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	THBS1
Immunoglobulin Class-Switch Recombination Activation	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	NFKBIA
CD4+ T-Cell Death in HIV	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	NFKBIA
RARA Signaling in Acute Myeloid Leukemia (M3)	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	STAT5A
SPP1 Induced Survival of Myelin Specific T-Cells in Multiple Sclerosis	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	NFKBIA
Vascular Smooth Muscle Cell Vasodilation in Brain	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	BDKRB2
RAS/RAF/MAPK Signaling Activation in Cancer	1/29	0.18083778280711155	0.2118315728428783	0	0	5.208771008403361	8.907805143996194	FOS
ADRA1A -> IL6 Production	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	FOS
High Fat Diet Activates cAMP Related Exocytosis in Synapse and Endocrine Cell	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	UNC13A
Male Sex Determination	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	CITED2
Androgens Promote Scalp Dermal Papilla Regression	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	DKK1
Apoptosis of Renal Tubule Epithelial Cell in Pyelonephritis	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	TNF
CD8+ T-Cell Action Impairment in HIV Type 1 Infection	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	FOS
CFTR Misfolding and Degradation (Class II Mutations)	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	HSPA1A
Enamel Formation Disruption	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	ID1
Genes with Mutations Associated with Vitiligo	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	TNF
Thyroid Hormones in Adipose Tissue Metabolism	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	STAT5A
BMPR2 Signaling	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	ID1
WNT Canonical Signaling	1/30	0.18645718406173262	0.21493338083078875	0	0	5.028904665314402	8.446315147566118	DKK1
Pancreatic Ductal Carcinoma	2/117	0.1912622370932607	0.21817965747688162	0	0	2.54402576489533	4.2080980090040665	STAT5A;FOS
Leukocyte Adhesion to Endothelial Cell	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	ICAM1
Macrophage M2-Related Phagocytosis	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	THBS1
Aldosterone Synthesis Chronic Regulation	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	FOS
B-Cell Mediated IgE Production in Asthma	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	NFKBIA
GNRH Signaling Impairment in Hypogonadotrophic Hypogonadism	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	FOS
Neutrophil and Macrophage Function in Systemic Lupus Erythematosus	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	TNF
Osteoblast Function Decline in Osteoporosis	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	FOS
ER Stress (Unfolded Protein Response)	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	HSPA1A
AngiopoietinR -> AP-1 Signaling	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	FOS
Hippo/YAP1 Signaling	1/31	0.19203831602803864	0.21817965747688162	0	0	4.861029411764706	8.020991961652324	ID1
B-Cell Activation in Crohn's Disease	1/32	0.19758143745515003	0.2235993320874449	0	0	4.7039848197343455	7.62800266036714	STAT5A
Hereditary Breast and Ovarian Cancer Syndrome	1/32	0.19758143745515003	0.2235993320874449	0	0	4.7039848197343455	7.62800266036714	FOS
Ovulation Block	1/32	0.19758143745515003	0.2235993320874449	0	0	4.7039848197343455	7.62800266036714	FOS
IGF1 Role in Muscle Hypertrophy	1/33	0.20308680529440165	0.22923192067040393	0	0	4.556755514705882	7.264023207811308	FOS
EphrinB -> MAPK/JUN/FOS Signaling	1/33	0.20308680529440165	0.22923192067040393	0	0	4.556755514705882	7.264023207811308	FOS
Prostate Cancer	2/123	0.20619262359195237	0.23243532114001902	0	0	2.417141108050199	3.8165316126297975	STAT5A;ETS1
SCF/BTRC Complex	1/34	0.20855467481700704	0.23388302033741873	0	0	4.418449197860962	6.926157902930394	NFKBIA
Proteins Involved in Acute Myeloid Leukemia	1/34	0.20855467481700704	0.23388302033741873	0	0	4.418449197860962	6.926157902930394	STAT5A
Proteins Involved in Breast Cancer Related to WNT Signaling Pathway	1/34	0.20855467481700704	0.23388302033741873	0	0	4.418449197860962	6.926157902930394	FOS
NGFR -> AP-1/CEBPB/CREB/ELK/SRF/TP53 Signaling	1/34	0.20855467481700704	0.23388302033741873	0	0	4.418449197860962	6.926157902930394	FOS
Receptors and Adaptor Proteins Activated in Cancer	2/125	0.2111981556986176	0.23654193438245175	0	0	2.3775971093044266	3.697064738813563	STAT5A;PLAU
GFs/TNF -> Ion Channels	1/35	0.21398529954966378	0.23812723078090792	0	0	4.288278546712803	6.611873529216499	TNF
IL22 Induces Keratinocyte Proliferation in Psoriasis	1/35	0.21398529954966378	0.23812723078090792	0	0	4.288278546712803	6.611873529216499	FOS
Neurotrophic Factor Deprivation in Retinal Ganglion Cell Death	1/35	0.21398529954966378	0.23812723078090792	0	0	4.288278546712803	6.611873529216499	NFKBIA
NOTCH1 Signaling in Breast Cancer	1/35	0.21398529954966378	0.23812723078090792	0	0	4.288278546712803	6.611873529216499	FOS
WNT Signaling in Breast Cancer	1/35	0.21398529954966378	0.23812723078090792	0	0	4.288278546712803	6.611873529216499	FOS
Proteins Involved in Retinitis Pigmentosa	2/127	0.2162158840540672	0.2403013922649556	0	0	2.3393185185185184	3.5826146290512226	FSCN2;TNF
Donohue Syndrome Progression (Hypothesis)	1/36	0.21937893133793554	0.242265791859196	0	0	4.165546218487395	6.318945182020532	STAT5A
Thyroid Dysfunction	1/36	0.21937893133793554	0.242265791859196	0	0	4.165546218487395	6.318945182020532	FOS
EPCAM in Cancer Cell Motility and Proliferation	1/36	0.21937893133793554	0.242265791859196	0	0	4.165546218487395	6.318945182020532	DKK1
JNK/MAPK Signaling	1/36	0.21937893133793554	0.242265791859196	0	0	4.165546218487395	6.318945182020532	FOS
Lysophosphatidic Acid/LPARs Signaling	1/36	0.21937893133793554	0.242265791859196	0	0	4.165546218487395	6.318945182020532	FOS
Ovarian Cancer	2/130	0.22376260849304808	0.24661275856851497	0	0	2.2841435185185186	3.419750175395477	STAT5A;FOS
Vascular Endothelial Cell Permeability Activation	1/37	0.22473582030840478	0.24661275856851497	0	0	4.049632352941177	6.045411444773934	NFKBIA
Th1-Cell Activation in Crohn's Disease	1/37	0.22473582030840478	0.24661275856851497	0	0	4.049632352941177	6.045411444773934	STAT5A
TERT Activation in Cancer	1/37	0.22473582030840478	0.24661275856851497	0	0	4.049632352941177	6.045411444773934	ETS1
PDGFR -> AP-1/MYC Signaling	1/37	0.22473582030840478	0.24661275856851497	0	0	4.049632352941177	6.045411444773934	FOS
Proteins Involved in Pulmonary Emphysema	1/38	0.2300562149832744	0.2518143689854756	0	0	3.9399841017488075	5.789537091199061	TNF
HGFR -> AP-1/CREB/MYC Signaling	1/38	0.2300562149832744	0.2518143689854756	0	0	3.9399841017488075	5.789537091199061	FOS
DRD2 Expression Targets	1/39	0.2353403621082968	0.25695023183648	0	0	3.8361068111455108	5.549781895253681	FOS
VEGFA in Neovascular Glaucoma	1/39	0.2353403621082968	0.25695023183648	0	0	3.8361068111455108	5.549781895253681	FOS
SIRT1 Signaling in Aging	1/40	0.24058850686050348	0.26202110910278176	0	0	3.737556561085973	5.324774409818904	HSPA1A
G0/G1 Phase Transition	1/40	0.24058850686050348	0.26202110910278176	0	0	3.737556561085973	5.324774409818904	FOS
Transcytosis	1/41	0.2458008927300703	0.2660288963711983	0	0	3.643933823529412	5.113289830471274	BDKRB2
Astrocytoma	1/41	0.2458008927300703	0.2660288963711983	0	0	3.643933823529412	5.113289830471274	ETS1
Insulin Resistance in Myocytes Induced by Obesity	1/41	0.2458008927300703	0.2660288963711983	0	0	3.643933823529412	5.113289830471274	CXCL5
RAS/RAF/MAPK Signaling Activation by Blocking of Tumor Suppressors	1/41	0.2458008927300703	0.2660288963711983	0	0	3.643933823529412	5.113289830471274	FOS
T-Cell Receptor -> NF-kB Signaling	1/41	0.2458008927300703	0.2660288963711983	0	0	3.643933823529412	5.113289830471274	NFKBIA
Sebocyte Proliferation in Acne Vulgaris	1/42	0.25097776157356577	0.27061949943584485	0	0	3.5548780487804876	4.914231218402292	FOS
HIF1A in Vasculogenic Mimicry of Cancer	1/42	0.25097776157356577	0.27061949943584485	0	0	3.5548780487804876	4.914231218402292	PLAU
EGFR -> AP-1/ATF2 Signaling	1/42	0.25097776157356577	0.27061949943584485	0	0	3.5548780487804876	4.914231218402292	FOS
IgE Induces Airway Smooth Muscle Cell Proliferation	1/43	0.25611935364957467	0.2747980209738329	0	0	3.470063025210084	4.72661350869186	NFKBIA
Proteins Involved in Mucinous Ovarian Carcinoma	1/43	0.25611935364957467	0.2747980209738329	0	0	3.470063025210084	4.72661350869186	FOS
WNT Signaling in Cystic Kidney Disease	1/43	0.25611935364957467	0.2747980209738329	0	0	3.470063025210084	4.72661350869186	FOS
VEGFR -> AP-1/CREB/MYC Signaling	1/43	0.25611935364957467	0.2747980209738329	0	0	3.470063025210084	4.72661350869186	FOS
Proteins Involved in Erectile Dysfunction	1/44	0.2612259075978302	0.2788980169679171	0	0	3.3891928864569083	4.549549837140044	TNF
HIF1A as Master Regulator of Angiogenesis in Cancer	1/44	0.2612259075978302	0.2788980169679171	0	0	3.3891928864569083	4.549549837140044	CCL2
FOXO1 Signaling	1/44	0.2612259075978302	0.2788980169679171	0	0	3.3891928864569083	4.549549837140044	SOD2
HRAS Signaling	1/44	0.2612259075978302	0.2788980169679171	0	0	3.3891928864569083	4.549549837140044	FOS
Melanoma	2/145	0.2617273661096673	0.2790901152127656	0	0	2.042994042994043	2.738535255559455	CXCL8;PLAU
CagA Phosphorylation Dependent Signaling	1/45	0.2662976604286021	0.2832676093774836	0	0	3.3119986631016043	4.382239804478489	FOS
Proteins Involved in Presbycusis	1/45	0.2662976604286021	0.2832676093774836	0	0	3.3119986631016043	4.382239804478489	TNF
Natural Killer Cell Activation through Integrins and non-ITAM-Containing Receptors	1/46	0.27133484756185794	0.2872178630288935	0	0	3.238235294117647	4.22395936672437	ICAM1
Oncogene Induced Cellular Senescence	1/46	0.27133484756185794	0.2872178630288935	0	0	3.238235294117647	4.22395936672437	FOS
Proteins Involved in Clear Cell Ovarian Carcinoma	1/46	0.27133484756185794	0.2872178630288935	0	0	3.238235294117647	4.22395936672437	FOS
Suppression of Caspase Activity in Cancer	1/46	0.27133484756185794	0.2872178630288935	0	0	3.238235294117647	4.22395936672437	BIRC3
Growth Factor Signaling in Neuroblastoma	1/47	0.2763377029023164	0.2910935996592362	0	0	3.1676790281329925	4.0740520966305604	NFKBIA
TGFBR Signaling in Pancreatic Neoplasms	1/47	0.2763377029023164	0.2910935996592362	0	0	3.1676790281329925	4.0740520966305604	FOS
ERK/MAPK Canonical Signaling	1/47	0.2763377029023164	0.2910935996592362	0	0	3.1676790281329925	4.0740520966305604	FOS
FibronectinR -> AP-1/ELK/SRF/SREBF Signaling	1/47	0.2763377029023164	0.2910935996592362	0	0	3.1676790281329925	4.0740520966305604	FOS
Vascular Smooth Muscle Cell/Pericyte Migration and Proliferation	1/48	0.28130645867119686	0.2948961426649745	0	0	3.1001251564455568	3.9319216086160855	FOS
Glioblastoma, Primary	1/48	0.28130645867119686	0.2948961426649745	0	0	3.1001251564455568	3.9319216086160855	ETS1
Proteins Involved in Endometrioid Ovarian Carcinoma	1/48	0.28130645867119686	0.2948961426649745	0	0	3.1001251564455568	3.9319216086160855	FOS
Proteins Involved in Low-Grade Serous Ovarian Carcinoma	1/48	0.28130645867119686	0.2948961426649745	0	0	3.1001251564455568	3.9319216086160855	FOS
Platelet Activation via GPCR Signaling	1/49	0.286241345606316	0.2986267884450508	0	0	3.0353860294117645	3.7970249652161496	PTAFR
Insulin Resistance in Hepatocytes	1/49	0.286241345606316	0.2986267884450508	0	0	3.0353860294117645	3.7970249652161496	TNF
Polycystins Mutation Effects in Cystic Kidney Disease	1/49	0.286241345606316	0.2986267884450508	0	0	3.0353860294117645	3.7970249652161496	FOS
EGFR -> AP-1/CREB/ELK/SRF/MYC Signaling	1/49	0.286241345606316	0.2986267884450508	0	0	3.0353860294117645	3.7970249652161496	FOS
Glioblastoma, Secondary	1/50	0.2911425929329805	0.3026488271447031	0	0	2.9732893157262907	3.668866926816198	ETS1
Podocyte Dysfunction in Glomerulonephritis	1/50	0.2911425929329805	0.3026488271447031	0	0	2.9732893157262907	3.668866926816198	TNF
Smooth Muscle Cell Dysfunction in Arterial Hypertension	1/50	0.2911425929329805	0.3026488271447031	0	0	2.9732893157262907	3.668866926816198	FOS
NTRK -> AP-1/CREB/ELK/SRF/MYC/SMAD3/TP53 Signaling	1/51	0.2960104282608464	0.30734097096939555	0	0	2.913676470588235	3.5469949209045577	FOS
Polycystic Ovary Syndrome	1/52	0.300845077626674	0.3119874879091434	0	0	2.856401384083045	3.4309946266330797	FOS
HPV E5 Regulates EDNRA and EGFR Signaling Pathway in Keratinocytes	1/53	0.3056467657251325	0.31658877404464797	0	0	2.801329185520362	3.320486088836687	FOS
T-Cell Receptor Signaling	1/54	0.3104157155874621	0.32000099896664747	0	0	2.7483351831298557	3.2151202959295317	NFKBIA
Atopic Dermatitis Onset	1/54	0.3104157155874621	0.32000099896664747	0	0	2.7483351831298557	3.2151202959295317	NFKBIA
G0/G1 Cell Cycle Phase Transition Activation in Cancer	1/54	0.3104157155874621	0.32000099896664747	0	0	2.7483351831298557	3.2151202959295317	FOS
FGFR -> AP-1/CREB/CREBBP/ELK/SRF/MYC Signaling	1/54	0.3104157155874621	0.32000099896664747	0	0	2.7483351831298557	3.2151202959295317	FOS
Th1-Cell Function in Systemic Lupus Erythematosus	1/55	0.3151521487915624	0.3244982979253572	0	0	2.6973039215686274	3.1145761497014353	ETS1
Hyaluronic Acid, CD44 and HMMR in Cancer Cell Invasion and Survival	1/56	0.31985628540782685	0.3289517248033101	0	0	2.648128342245989	3.018557782468822	BIRC3
Angiogenesis in Endometriosis	1/57	0.32452834409284537	0.3321823144723936	0	0	2.6007090336134455	2.926792173115241	FOS
Genes with Mutations Associated with Retinitis Pigmentosa	1/57	0.32452834409284537	0.3321823144723936	0	0	2.6007090336134455	2.926792173115241	FSCN2
Proteins Involved in High-Grade Serous Ovarian Carcinoma	1/57	0.32452834409284537	0.3321823144723936	0	0	2.6007090336134455	2.926792173115241	FOS
Th2-Cell Function in Ulcerative Colitis	1/57	0.32452834409284537	0.3321823144723936	0	0	2.6007090336134455	2.926792173115241	NFKBIA
Peripheral T-Cell Tolerance	1/58	0.3291685419887074	0.3357441767875417	0	0	2.554953560371517	2.839027026793925	TNF
Myoblast -> Neutrophil Surface Expression Markers	1/58	0.3291685419887074	0.3357441767875417	0	0	2.554953560371517	2.839027026793925	SDC4
VEGF Signaling	1/58	0.3291685419887074	0.3357441767875417	0	0	2.554953560371517	2.839027026793925	FOS
Steroids Induced Cataract	1/59	0.3337770947455803	0.34004520920089637	0	0	2.5107758620689653	2.755028882806623	FOS
Neutrophil Degranulation via FPR1 Signaling	1/62	0.3474150174537504	0.35311034560872995	0	0	2.386933461909354	2.5235500711559498	CXCL8
TGF-beta Signaling	1/62	0.3474150174537504	0.35311034560872995	0	0	2.386933461909354	2.5235500711559498	FOS
Th1-Cell Differentiation	1/64	0.35635262977237486	0.3609265841801883	0	0	2.310924369747899	2.3844915038810557	NFKBIA
Cetuximab Resistance in Colorectal Cancer	1/64	0.35635262977237486	0.3609265841801883	0	0	2.310924369747899	2.3844915038810557	STAT5A
Myeloblast -> Neutrophil Surface Expression Markers	1/64	0.35635262977237486	0.3609265841801883	0	0	2.310924369747899	2.3844915038810557	ICAM1
Androgens in Sebocyte Maturation	1/65	0.3607757607501965	0.36498060644658575	0	0	2.274701286764706	2.3190549478926425	DKK1
Pancreatic Neuroendocrine Tumors	1/71	0.3866879681857055	0.3907394137196652	0	0	2.079096638655462	1.9754270482442287	FOS
Glioma Stem Cell Program Activation	1/72	0.3909041152642434	0.39454043261553867	0	0	2.0497100248550124	1.9252782344583481	DKK1
TGFB Signaling activation by Blocking of Tumor Suppressors	1/73	0.395091488951388	0.398303614877822	0	0	2.021139705882353	1.876906979173357	FOS
TGFB Family in Epithelial to Mesenchymal Transition in Cancer	1/80	0.423613659972373	0.4265622469327376	0	0	1.8413998510796723	1.5816398687969306	ID1
Vascular Motility	1/85	0.44316530874453697	0.4457328945425934	0	0	1.7313550420168067	1.4089982385378543	BDKRB2
Cell Cycle Overiew	1/107	0.5216598069580667	0.5240748986569466	0	0	1.3704911209766926	0.8918328635531109	FOS
Ca2+ Flux Regulation	1/109	0.5282257770666134	0.5300577739812953	0	0	1.3449754901960784	0.8584056957797925	BDKRB2
Genes with Mutations in Cancer-Associated Sustaining of Proliferative Signaling	1/112	0.5379073369162519	0.539149617140077	0	0	1.3084260731319555	0.8113144073177951	BIRC3
Neuroblastoma	1/131	0.5948042369447535	0.5954902856609527	0	0	1.1161199095022625	0.57984989801779	NFKBIA
Proteins with Altered Expression in Cancer-Associated Sustaining of Proliferative Signaling	1/175	0.7012513857463855	0.7012513857463855	0	0	0.8320233265720081	0.2952757982440509	PLAU
